BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8263-8276 [PMID: 29307986 DOI: 10.3748/wjg.v23.i47.8263]
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8263.htm
(465) (537) (0) (0) (30) (39302) (629)
Number Citing Articles
1
Mahider Shimelis Feyisa, Sintayehu Ambachew, Alemie Fentie Mebratie, Bruktawit Eshetu Ali, Rishan Hadgu Asefa, Elias Chane Asefa, Mahder Girma Asmamaw, Getnet Fetene. Nonalcoholic Fatty Liver Disease Status and Its Associated Factors Among Patients With Type 2 Diabetes Mellitus in Adama Hospital Medical College, South Eastern Ethiopia: A Cross‐Sectional Study. Health Science Reports 2026; 9(2) doi: 10.1002/hsr2.71773
2
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. F1000Research 2020; 9 doi: 10.12688/f1000research.21918.1
3
Eveline Gart, Wim van Duyvenvoorde, Martien P. M. Caspers, Nikki van Trigt, Jessica Snabel, Aswin Menke, Jaap Keijer, Kanita Salic, Martine C. Morrison, Robert Kleemann. Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH. The FASEB Journal 2022; 36(8) doi: 10.1096/fj.202200111R
4
Plator Memaj, Zayd Ouzerara, François R. Jornayvaz. Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411271
5
Brian A. Telfer, Viksit Kumar, Aaron D. Aguirre, Anthony E. Samir, Laura J. Brattain. Machine Learning in Cardiovascular Medicine. 2021;  doi: 10.1016/B978-0-12-820273-9.00008-7
6
Yi-Shu Chen, Dan Chen, Chao Shen, Ming Chen, Chao-Hui Jin, Cheng-Fu Xu, Chao-Hui Yu, You-Ming Li. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterology Report 2021; 9(1) doi: 10.1093/gastro/goaa035
7
Fatemeh Mohtashaminia, Mohammad Reza Amini, Fatemeh Sheikhhossein, Kurosh Djafarian, Sakineh Shab-Bidar. Effects berberine–silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 2022; 49 doi: 10.1016/j.clnesp.2022.01.037
8
Maged Tharwat Elghannam, Moataz Hassan Hassanien, Ahmed Aly ELRay, Hoda Mohamed Abu-Taleb, Yosry Abdelrahman Ameen, Gamal Mohammed ELattar, Emad Abdelwahab Turky, Mohammed Darwish ELTalkawy. Hepatic fibrosis in morbidly obese patients: fibroscan accuracy. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100575
9
Amir Mohammad Salehi, Hossain Salehi, Alireza Sadeghi, Maryam Hasanzarrini, Salman Khazaei, Hossein Ali Mohammadi, Mahvash Alizade Naini, Neetu Rawal. Can Noninvasive Tests Reduce the Need for Liver Biopsy? A Cross‐Sectional Diagnostic Accuracy Study Assessing NFS, FIB‐4, APRI, BARD, BAAT, API, and AAR for Advanced Fibrosis in MASLD Patients in Iran. International Journal of Clinical Practice 2026; 2026(1) doi: 10.1155/ijcp/6674792
10
Risa M. Wolf, Kiyoko Oshima, Joseph K. Canner, Kimberley E. Steele. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery. Surgery for Obesity and Related Diseases 2019; 15(10) doi: 10.1016/j.soard.2019.08.013
11
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
12
Yanfeng Li, Jiayi Li, Ruixue Zhao, Jiameng Wang. Association of body mass index and visceral fat with heart rate variability in university students: a BMI-stratified analysis. Frontiers in Physiology 2026; 17 doi: 10.3389/fphys.2026.1830583
13
Tao Jiang, Xiao-jing Guo, Li-ping Tu, Zhou Lu, Ji Cui, Xu-xiang Ma, Xiao-juan Hu, Xing-hua Yao, Long-tao Cui, Yong-zhi Li, Jing-bin Huang, Jia-tuo Xu. Application of computer tongue image analysis technology in the diagnosis of NAFLD. Computers in Biology and Medicine 2021; 135 doi: 10.1016/j.compbiomed.2021.104622
14
Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30(6) doi: 10.1016/j.numecd.2020.02.016
15
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Clinics in Liver Disease 2019; 23(3) doi: 10.1016/j.cld.2019.05.001
16
Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian Lam, Amir H. Moazez, Hazem A. Elariny, Zachary Goodman, Zobair M. Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity Surgery 2021; 31(5) doi: 10.1007/s11695-020-04996-1
17
Jill Roberts Hobbs, Kimberly Ellison Wilson. Obesity in Primary Care: A Case of Endocrine-Associated Conditions. The Journal for Nurse Practitioners 2023; 19(3) doi: 10.1016/j.nurpra.2022.10.018
18
Mengmeng Hou, Qi Gu, Jiawei Cui, Yao Dou, Xiuhong Huang, Jie Li, Liang Qiao, Yuemin Nan. Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population. Chinese Medical Journal 2025; 138(7) doi: 10.1097/CM9.0000000000003141
19
Keerthi Thallapureddy, David Twitchell, Kristen Ott, Lisa D. Pedicone, Chioma Owo, Nina Kumar, Jonathan Gelfond, Nagasri Shankar, Martin Goros, Daisy Kwok, Anna Liles, Fatma Ozguc, Iqra Kazi, Harry Nguyen, Eric Lawitz, Eugenia Tsai, Fabian Rodas, Carmen E. Landaverde, Fred Poordad. The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease. Medicine 2025; 104(17) doi: 10.1097/MD.0000000000042016
20
Jotham Josephat Kimondo, Yi Hu, Junjie Xue, Bangyi Luo, Ziang Feng, Jun Wu, Zhe Wu, Fahad Farhan Almutairi. Establishing an Elastography calibration standard: Validation of a shear wave TOF device for measuring Elasticity and Viscosity in tissue-mimicking phantoms using rheometry. PLOS One 2025; 20(11) doi: 10.1371/journal.pone.0335645
21
Antonio Mirijello, Gabriella Pacilli, Antonio Siena, Antonio Mangiacotti, Maria Maddalena D'Errico, Daria Dilalla, Olga Lamacchia, Andrea Fontana, Massimiliano Copetti, Pamela Piscitelli, Giovanni Targher, Salvatore A. De Cosmo. The Fibrosis-4 index predicts all-cause mortality in a cohort of patients at high cardiovascular risk partly through glomerular filtration rate reduction. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(1) doi: 10.1016/j.numecd.2024.10.007
22
Libby Stein, Rasham Mittal, Hubert Song, Joanie Chung, Amandeep Sahota. To scan or not to scan: Use of transient elastography in an integrated health system. World Journal of Hepatology 2023; 15(3): 419-430 doi: 10.4254/wjh.v15.i3.419
23
Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. Obesity Surgery 2022; 32(2) doi: 10.1007/s11695-021-05797-w
24
Yu A. An, Shiuhwei Chen, Yingfeng Deng, Zhao V. Wang, Jan-Bernd Funcke, Manasi Shah, Bo Shan, Ruth Gordillo, Jun Yoshino, Samuel Klein, Christine M. Kusminski, Philipp E. Scherer. The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis. Journal of Hepatology 2021; 75(2) doi: 10.1016/j.jhep.2021.03.006
25
Lionel Fizanne, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, Xavier Vidal‐Gómez, Thibauld Oullier, Samuel Chaffron, M. Carmen Martínez, Michel Neunlist, Jérôme Boursier, Ramaroson Andriantsitohaina. Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases. Journal of Extracellular Vesicles 2023; 12(2) doi: 10.1002/jev2.12303
26
Xiangmeng Chen, Teng Ma, Rowena Yip, Ponni V. Perumalswami, Andrea D. Branch, Sara Lewis, Michael Crane, David F. Yankelevitz, Claudia I. Henschke. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clinical Imaging 2020; 60(2) doi: 10.1016/j.clinimag.2019.12.009
27
Nan Xu, Huijuan Luo, Minyao Li, Jiazhen Wu, Xue Wu, Liping Chen, Yuxuan Gan, Fengkun Guan, Mengyao Li, Ziren Su, Jiannan Chen, Yuhong Liu. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. Biomedicine & Pharmacotherapy 2021; 134 doi: 10.1016/j.biopha.2020.111104
28
Ahmed M Baradeiya, Khaled M Taghlabi, Abdelhalim N Saleh, Sindhura Manikonda, Siffat S Salim. Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?. Cureus 2023;  doi: 10.7759/cureus.40849
29
Salvatore Corrao, Giuseppe Natoli, Christiano Argano. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis. European Journal of Gastroenterology & Hepatology 2021; 33(1) doi: 10.1097/MEG.0000000000001684
30
Shantan Cheemerla, Maya Balakrishnan. Global Epidemiology of Chronic Liver Disease. Clinical Liver Disease 2021; 17(5) doi: 10.1002/cld.1061
31
Yiwei Hang, Christine Lee, Youssef M Roman. Assessing the Clinical Utility of Major Indices for Nonalcoholic Fatty Liver Disease in East Asian Populations. Biomarkers in Medicine 2023; 17(8) doi: 10.2217/bmm-2023-0172
32
Hafiza Madiha Jaffar, Fahad Al‐Asmari, Faima Atta Khan, Muhammad Abdul Rahim, Eliasse Zongo. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review. Food Science & Nutrition 2024; 12(5) doi: 10.1002/fsn3.4010
33
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1) doi: 10.3390/biom12010056
34
Ji‐Mu Wu, Getu Zhaori, Li Mei, Xiao‐Man Ren, Arong Tong Laga, Batu Deligen. Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease viaAMPK/Nrf2 elevation. The Kaohsiung Journal of Medical Sciences 2023; 39(8) doi: 10.1002/kjm2.12712
35
Liuxin Zhang, Mengting Zhang, Min Wang, Minxian Wang, Ru Zhang, Hongliang Wang, Wei Zhang, Yajie Ding, Jie Wang. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population. European Journal of Gastroenterology & Hepatology 2022; 34(8) doi: 10.1097/MEG.0000000000002399
36
Ifrath Parveen, Archana Prabhat. Energy Intake and Lifestyle Risk Factors among Non Alcoholic Fatty Liver Disease Patients. The Indian Journal of Nutrition and Dietetics 2020;  doi: 10.21048/ijnd.2020.57.3.25563
37
Yuwei Wu, Jinyu Wang, Xiaodong Zheng, Yongyan Chen, Mei Huang, Qiang Huang, Weihua Xiao, Haiming Wei, Zhigang Tian, Rui Sun, Cheng Sun. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model. Immunology Letters 2020; 223 doi: 10.1016/j.imlet.2020.04.009
38
Dajana Lichtenstein, Claudia Luckert, Jimmy Alarcan, Georges de Sousa, Michail Gioutlakis, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad Peijnenburg, Roger Rahmani, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana J. Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Albert Braeuning, Alfonso Lampen. An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro. Food and Chemical Toxicology 2020; 139 doi: 10.1016/j.fct.2020.111283
39
Yangjun Liu, Wei Xie, Juan Li, Zbigniew Ossowski. Effects of aerobic exercise on metabolic indicators and physical performance in adult NAFLD patients: A systematic review and network meta-analysis. Medicine 2023; 102(14) doi: 10.1097/MD.0000000000033147
40
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
41
Somaya Albhaisi, Arun Sanyal. Recent advances in understanding and managing non-alcoholic fatty liver disease. F1000Research 2018; 7 doi: 10.12688/f1000research.14421.1
42
Hanui Jo, Lipjung Jung, Nuri Kim, Gi-Wook Kim, Dongwon Lee. Bile acid-based polydrug nanoparticles for the treatment of acute liver injury. Macromolecular Research 2024; 32(5) doi: 10.1007/s13233-023-00241-7
43
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease. Medicine 2020; 99(36) doi: 10.1097/MD.0000000000021463
44
Oscar Danielsson, Jana Nano, Katja Pahkala, Susanne Rospleszcz, Terho Lehtimäki, Christopher L. Schlett, Mika Kähönen, Fabian Bamberg, Olli Raitakari, Annette Peters, Markku J. Nissinen, Fredrik O. Åberg. Validity of fatty liver disease indices in the presence of alcohol consumption. Scandinavian Journal of Gastroenterology 2022; 57(11) doi: 10.1080/00365521.2022.2085060
45
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis. The American Journal of Pathology 2021; 191(9) doi: 10.1016/j.ajpath.2021.05.020
46
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery. World Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
47
Guoqing Huang, Qiankai Jin, Yushan Mao. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study. Journal of Medical Internet Research 2023; 25 doi: 10.2196/46891
48
Jian Ju, Mozaniel Santana de Oliveira, Yu Qiao. Cinnamon: A Medicinal Plant and A Functional Food Systems. Food Bioactive Ingredients 2023;  doi: 10.1007/978-3-031-33505-1_16
49
Evgeniy V. Kryukov, Dmitry V. Cherkashin, Vladimir V. Saluhov, Konstantin V. Matjushenko, Aleksey D. Sobolev, Nikolaj N. Shcherbina. Extrahepatic manifestations of chronic viral hepatitis C. Bulletin of the Russian Military Medical Academy 2022; 24(2) doi: 10.17816/brmma103982
50
Yimeng Shu, Guoqing Huang, Yushan Mao. The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects. Diabetes, Metabolic Syndrome and Obesity 2023;  doi: 10.2147/DMSO.S438975
51
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022 doi: 10.1155/2022/4344905
52
Giovanni GALLETTI, Elena FORMISANO, Andrea GHEZZI, Matteo TOZZI, Sharmila FAGOONEE, Enzo ANDORNO, Paolo BORRO. Non-invasive staging of hepatic steatosis by Quantification Attenuation Index (QAI). Minerva Gastroenterology 2026; 72(1) doi: 10.23736/S2724-5985.25.03829-X
53
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP Reports 2020; 2(5) doi: 10.1016/j.jhepr.2020.100142
54
Seungtae On, Hyun Young Kim, Hyo Seon Kim, Jeongwoo Park, Keon Wook Kang. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes. International Journal of Molecular Sciences 2019; 20(11) doi: 10.3390/ijms20112625
55
Peter M. Graffy, Veit Sandfort, Ronald M. Summers, Perry J. Pickhardt. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment. Radiology 2019; 293(2) doi: 10.1148/radiol.2019190512
56
Sang Joon An, Eun-Jung Yang, Subin Oh, Kyong Jin Park, Taehyen Kim, Yeon-pyo Hong, Yun-Jung Yang. The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. Environmental Health and Preventive Medicine 2021; 26(1) doi: 10.1186/s12199-021-01010-7
57
Sayma Yaqub, Patricia Ananias, Arpita Shah, Kanita Luenam, Arunima Mariya Jose, Joao Pedro Melo, Arifa Turkistani, Lubna Mohammed. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. Cureus 2021;  doi: 10.7759/cureus.18201
58
Jesse Pustjens, Laurens A. van Kleef, Zobair M. Younossi, Christophe Moreno, Harry L. A. Janssen, Maja Thiele, Willem P. Brouwer. Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption. Hepatology Research 2026; 56(3) doi: 10.1111/hepr.70067
59
Atsuhiro Nagasaki, Shinnichi Sakamoto, Toshiki Arai, Minami Kato, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. Journal of Clinical Periodontology 2021; 48(10) doi: 10.1111/jcpe.13523
60
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(6) doi: 10.1515/jbcpp-2021-0285
61
Gabriela Svobodová, Martin Horní, Eva Velecká, Iva Boušová. Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review. Archives of Toxicology 2025; 99(1) doi: 10.1007/s00204-024-03889-x
62
Manca Povsic, On Yee Wong, Richard Perry, Juliana Bottomley. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). Advances in Therapy 2019; 36(7) doi: 10.1007/s12325-019-00960-3
63
Sejeong Lee, Jaehyun Bae, Seung Up Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee. Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1306134
64
Ashis Kumar Saha, Puja Mahato, Aritra Kumar Ray, Ipshita Chatterjee, Moyukh Mukherjee. Correlation of Lipid Profile, LFT, AST/ALT Ratio, BARD, FIB-4, NFS Score, TyG Index with Transient Elastography to Detect Better Noninvasive Marker in Overweight and Obese Patient in Tertiary Care Center, West Bengal: A Cross-Sectional Observational Study. International Journal of Health Sciences and Research 2026;  doi: 10.52403/ijhsr.20260136
65
Jose Hernandez Roman, Samarth Patel. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease?. Gastroenterology Clinics of North America 2020; 49(1) doi: 10.1016/j.gtc.2019.10.001
66
Pang-Yen Liu, Yu-Kai Lin, Kai-Wen Chen, Kun-Zhe Tsai, Yen-Po Lin, Eiki Takimoto, Gen-Min Lin. Association of Liver Transaminase Levels and Long-Term Blood Pressure Variability in Military Young Males: The CHIEF Study. International Journal of Environmental Research and Public Health 2020; 17(17) doi: 10.3390/ijerph17176094
67
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5) doi: 10.26442/20751753.2023.5.202272
68
Yunjie Liao, Nathan A. Davies, I. David L. Bogle. Chemical Engineering Principles Applied to Medicine. 2025;  doi: 10.1515/9783111394558-002
69
Xianwen Chen, Junnan Shi, Yunfeng Lai, Yan Xue, Carolina Oi Lam Ung, Hao Hu. Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00761-5
70
Hyun Ho Jo, Changwook Min, Dae-Sung Kyoung, Min-Ae Park, Sang Gyune Kim, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon, Jeong-Ju Yoo, Chun Chieh Yeh. Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study. PLOS ONE 2021; 16(6) doi: 10.1371/journal.pone.0253165
71
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2021.9630
72
S-J Zhang, K Xu, F Zhu, J-G Chen, Y Zhang, Y-Q Teng, F-F Shen. Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction‑Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARα Pathway. Physiological Research 2026;  doi: 10.33549/physiolres.935711
73
Takahiro Iwasaki, Akiko Hirose, Tetsuji Azuma, Tamie Ohashi, Kazutoshi Watanabe, Akihiro Obora, Fumiko Deguchi, Takao Kojima, Atsunori Isozaki, Takaaki Tomofuji. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25857-z
74
Mary A. Foutz, Emily L. Krinos, Martina Beretta, Stefan R. Hargett, Riya Shrestha, Jacob H. Murray, Ethan Duerre, Joseph M. Salamoun, Katrina McCarter, Divya P. Shah, Kyle L. Hoehn, Webster L. Santos. Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4-b]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry 2024; 67(23) doi: 10.1021/acs.jmedchem.4c02366
75
Yee Hui Yeo, Linda Henry, Mindie H. Nguyen. Metabolic Steatotic Liver Disease. 2024;  doi: 10.1016/B978-0-323-99649-5.00002-9
76
Yingying Liu, Xinkui Liu, Wei Zhou, Jingyuan Zhang, Jiarui Wu, Siyu Guo, Shanshan Jia, Haojia Wang, Jialin Li, Yingying Tan. Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease. Medicine 2022; 101(36) doi: 10.1097/MD.0000000000030184
77
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7) doi: 10.1016/j.heliyon.2024.e28468
78
Sangwon F. Kim, Jang Hyun Choi. Metabolic Syndrome. 2023;  doi: 10.1007/978-3-319-12125-3_36-2
79
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/5649575
80
Lingxi Kong, Yang Yang, Haidong Li, Youlan Shan, Xin Wang, Xuefeng Shan. Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1127489
81
Rebeca Escutia-Gutiérrez, J. Samael Rodríguez-Sanabria, C. Alejandra Monraz-Méndez, Jesús García-Bañuelos, Arturo Santos-García, Ana Sandoval-Rodríguez, Juan Armendáriz-Borunda. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91187-2
82
Jesús Funuyet-Salas, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, Luke Vale, Tomos Robinson, Quentin M. Anstee, Manuel Romero-Gómez, Matias A. Avila. Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0300362
83
Tatyana S. Krolevets, Maria A. Livzan, Maria I. Syrovenko. Liver Fibrosis in Some Patients with Non-Alcoholic Fatty Liver Disease: from Diagnosis to Prognosis. Annals of the Russian academy of medical sciences 2024; 79(4) doi: 10.15690/vramn15829
84
Maja Szymanska, Daanyaal Mahmood, Timothy E. Yap, Maria F. Cordeiro. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease. International Journal of Molecular Sciences 2021; 22(17) doi: 10.3390/ijms22179441
85
Joseph M. Salamoun, Emily L. Krinos, Mary A. Foutz, Stefan R. Hargett, Martina Beretta, Riya Shrestha, Kyle L. Hoehn, Webster L. Santos. Design, synthesis, and biological evaluation of imidazo[4,5-b]pyridine mitochondrial uncouplers for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). European Journal of Medicinal Chemistry 2024; 280 doi: 10.1016/j.ejmech.2024.116916
86
Siqi Zhang, Hara Lee, Hong Ryul Ahn, Hocheol Kim, Hyun Ok Yang, Ki-Yeon Yoo, Gakyung Lee, Joonki Kim. Herbal mixture of Platycodon grandiflorum, Cinnamomum cassia, and Asiasarum sieboldii extracts protects against NASH progression via regulation of hepatic steatosis, inflammation, and apoptosis. Phytomedicine 2025; 145 doi: 10.1016/j.phymed.2025.157077
87
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver mice. World Chinese Journal of Digestology 2020; 28(4) doi: 10.11569/wcjd.v28.i4.113
Abstract(0) |  Core Tip(0) |  Full Article(HTML)(0) | Times Cited (2) | Total Visits (0) | Open
88
. 2019;  doi: 10.70675/2c39bb73z8509z4902z9e40ze0b995ba218b
89
Cornelius von Morze, Tyler Blazey, Mark S. Conradi. Quantifying Liver Fat Using a Low-Field Unilateral MR System. Applied Magnetic Resonance 2023; 54(11-12) doi: 10.1007/s00723-023-01595-y
90
Tian-Hao Yuan, Zhen-Sheng Yue, Guo-Heng Zhang, Lin Wang, Guo-Rui Dou. Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.823277
91
Farzad Salmanizadeh, Sakineh Sabzevari, Sara Shafieipour, Mohammad Javad Zahedi, Afshin Sarafinejad. Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03921-z
92
Shiwei Li, Yuhong Fu, Yue Liu, Xinxin Zhang, Haijun Li, Lei Tian, Lin Zhuo, Ming Liu, Jingqiu Cui. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism 2022; 107(8) doi: 10.1210/clinem/dgac190
93
Cosmas Rinaldi A. Lesmana, Meudia Syahidah, Irsan Hasan, Rino A. Gan. The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease. European Medical Journal 2019;  doi: 10.33590/emj/10310251
94
Pijun Yan, Yuru Wu, Xiaofang Dan, Xian Wu, Qian Tang, Xiping Chen, Yong Xu, Jianhua Zhu, Ying Miao, Qin Wan. Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1064125
95
Han Fang, Zhuoyue Li, Emily C. Graff, Kayleen J. McCafferty, Robert L. Judd. Niacin increases diet-induced hepatic steatosis in B6129 mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(9) doi: 10.1016/j.bbalip.2020.158731
96
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020184
97
Roberta Forlano, Benjamin H. Mullish, Rooshi Nathwani , Ameet Dhar, Mark R. Thursz, Pinelopi Manousou . Non-Alcoholic Fatty Liver Disease and Vascular Disease. Current Vascular Pharmacology 2020; 19(3) doi: 10.2174/1570161118666200318103001
98
Antonio De Vincentis, Zahra Rahmani, Moises Muley, Umberto Vespasiani-Gentilucci, Sergio Ruggiero, Parvin Zamani, Tannaz Jamialahmadi, Amirhossein Sahebkar. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment. Drug Discovery Today 2020; 25(7) doi: 10.1016/j.drudis.2020.05.009
99
Yinhua Ni, Yufeng Zhao, Lingyan Ma, Zhe Wang, Liyang Ni, Luting Hu, Zhengwei Fu. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability. Metabolism 2021; 114 doi: 10.1016/j.metabol.2020.154409
100
Hideo Ohuchi. What are the mechanisms for FALD and how can we prevent the progression?. International Journal of Cardiology 2018; 273 doi: 10.1016/j.ijcard.2018.09.071
101
Yunjie Liao, Nathan A. Davies, I. David L. Bogle. Computational modelling in liver system and liver disease. Physical Sciences Reviews 2025; 10(1-2) doi: 10.1515/psr-2024-0051
102
Aunchalee Jaroenlapnopparat, Pichatorn Suppakitjanusant, Ben Ponvilawan, Nipith Charoenngam. Vitamin D-Related Genetic Variations and Nonalcoholic Fatty Liver Disease: A Systematic Review. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23169122
103
Xiaobo Zhang, Rui Gao, Zhen Zhou, Jiayi Sun, Xuehua Tang, Jialiang Li, Xin Zhou, Tao Shen. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. Journal of Ethnopharmacology 2022; 296 doi: 10.1016/j.jep.2022.115405
104
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver International 2019; 39(9) doi: 10.1111/liv.14167
105
Valentina A. Zavala, Paige M. Bracci, John M. Carethers, Luis Carvajal-Carmona, Nicole B. Coggins, Marcia R. Cruz-Correa, Melissa Davis, Adam J. de Smith, Julie Dutil, Jane C. Figueiredo, Rena Fox, Kristi D. Graves, Scarlett Lin Gomez, Andrea Llera, Susan L. Neuhausen, Lisa Newman, Tung Nguyen, Julie R. Palmer, Nynikka R. Palmer, Eliseo J. Pérez-Stable, Sorbarikor Piawah, Erik J. Rodriquez, María Carolina Sanabria-Salas, Stephanie L. Schmit, Silvia J. Serrano-Gomez, Mariana C. Stern, Jeffrey Weitzel, Jun J. Yang, Jovanny Zabaleta, Elad Ziv, Laura Fejerman. Cancer health disparities in racial/ethnic minorities in the United States. British Journal of Cancer 2021; 124(2) doi: 10.1038/s41416-020-01038-6
106
Israel Rico-Alba, Alberto Retana-Guzmán, Marcela Agudelo-Botero, Claudio Alberto Dávila-Cervantes. Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study. Annals of Hepatology 2026; 31(2) doi: 10.1016/j.aohep.2026.102224
107
Karen Hye-cheon Kim Yeary, Amanda J. Quisenberry, Marissa G. Hall, Han Yu, Whitney Ann E. Henry, Elisa Marie Rodriguez, Jamie M. Zoellner. Sweet Beverages and Cancer: A Scoping Review of Quantitative Studies. Cancer Prevention Research 2022; 15(6) doi: 10.1158/1940-6207.CAPR-21-0507
108
Steffen Landerer, Sandra Kalthoff, Stefan Paulusch, Christian P. Strassburg. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65481-4
109
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine 2020; 9(11) doi: 10.3390/jcm9113409
110
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021;  doi: 10.2147/DMSO.S300051
111
Dongmei Zou, Liang Liu, Yinzhen Zeng, Huanhuan Wang, Dongling Dai, Mingguo Xu. LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-00889-7
112
Cheng Fang, Paul S. Sidhu. Ultrasound-based liver elastography: current results and future perspectives. Abdominal Radiology 2020; 45(11) doi: 10.1007/s00261-020-02717-x
113
Yu-Cheng Lin, Chi-Chien Wu, Yen-Hsuan Ni. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.603654
114
David L. Fisher , Stephen Malnick. Liver and COVID-19 - A Review and Clinical Approach. Coronaviruses 2022; 3(1) doi: 10.2174/2666796702666211005142343
115
Minjie Lin, Jungke Long, Wenbo Li, Chenxuan Yang, Patricia Loughran, Robert O’Doherty, Timothy R. Billiar, Meihong Deng, Melanie J. Scott. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding. Molecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00227-6
116
Nemry Rodríguez-Hernández, María-Luisa Lazo-de-la-Vega-Monroy, Yeniley Ruiz-Noa, Monica-del-Carmen Preciado-Puga, Juana-Rosalba Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Lorena-del-Rocío Ibarra-Reynoso. Predictive Models for Non-Alcoholic Fatty Liver Disease Diagnosis in Mexican Patients with Gallstone Disease: Sex-Specific Insights. Diagnostics 2024; 14(14) doi: 10.3390/diagnostics14141487
117
O. J. Kolawole, M. M. Oje, O. A. Betiku, O. Ijarotimi, O. Adekanle, D. A. Ndububa. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03237-4
118
Stefan Chiriac, Carol Stanciu, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Anca Trifan, Branka Filipović. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/6696857
119
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119220
120
Muhammad Yosif, Muhammad Azhar Khan, Raqiqa Tur Rasool, Shagufta Gulbadan, Haya Alhummiany, Muhammad Junaid, Zahra Bayhan, Zeshan Javed, Khalid Mahmood, Amal A. Abdel Hafez, M. Irfan, Majid Niaz Akhtar. Impact of Gd-substitution on structural, dielectric, spectroscopic, Raman, and photo luminance properties of Ba0.4Sr0.6Co2Fe16O27 ceramics. Materials Chemistry and Physics 2024; 324 doi: 10.1016/j.matchemphys.2024.129701
121
Antonio Gnoni, Benedetta Di Chiara Stanca, Laura Giannotti, Gabriele Vincenzo Gnoni, Luisa Siculella, Fabrizio Damiano. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031044
122
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00104
123
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4) doi: 10.15406/ghoa.2021.12.00469
124
Nina L. Gluchowski, Katlyn R. Gabriel, Chandramohan Chitraju, Roderick T. Bronson, Niklas Mejhert, Sebastian Boland, Kun Wang, Zon Weng Lai, Robert V. Farese, Tobias C. Walther. Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. Hepatology 2019; 70(6) doi: 10.1002/hep.30765
125
Dandan Song, Chengqian Li, Zhongchao Wang, Yuhang Zhao, Baoming Shen, Wenjuan Zhao. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies. Journal of Diabetes Investigation 2021; 12(8) doi: 10.1111/jdi.13489
126
Aderonke Gbemi Adetunji, Emmanuel Obeng-Gyasi. Investigating the Interplay of Toxic Metals and Essential Elements in Liver Disease. International Journal of Environmental Research and Public Health 2024; 21(6) doi: 10.3390/ijerph21060762
127
Svetlana Y. Kozlovich, Amy Y. Pan, Jennifer J. McIntosh, Anna Palatnik, Shuang Jia, Martin J. Hessner, T. Hang Nghiem-Rao. Hepatocyte reporter cells and integrated metabolomic and transcriptomic analyses reveal insights into hepatocyte changes in offspring of pregnancies with obesity. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-10808-2
128
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18) doi: 10.1097/MD.0000000000015362
129
Liu Li, Li Yang, Feng Yang, Xin-lan Zhao, Shengjiang Xue, Fang-hua Gong. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. Journal of Inflammation Research 2021;  doi: 10.2147/JIR.S302934
130
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
131
Mohammad Alizadeh, Mohammadreza Mohammad Hosseiniazar, Farkhondeh Alami, Somayyeh Bararnia Adabi. The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. Journal of Diabetes & Metabolic Disorders 2024; 23(1) doi: 10.1007/s40200-023-01375-2
132
Leslimar Rios-Colon, Elena Arthur, Suryakant Niture, Qi Qi, John T. Moore, Deepak Kumar. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells. Cells 2020; 9(9) doi: 10.3390/cells9091988
133
Andrew Ndakotsu, Govinathan Vivekanandan. The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022;  doi: 10.7759/cureus.25380
134
Tzu-chia Kuo, Yang-bor Lu, Chieh-lun Yang, Bin Wang, Lin-xin Chen, Ching-ping Su. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03095-6
135
Aparamita Pandey, Prachi Dabhade, Anand Kumarasamy. Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue. Dose-Response 2019; 17(2) doi: 10.1177/1559325819843380
136
Yifang Zhou, Xinhua Li. Liver fat volume fraction assessment in medium and large anthropomorphic phantoms–dual energy virtual monochromatic imaging versus single‐energy CT. Medical Physics 2025; 52(9) doi: 10.1002/mp.18105
137
A. Tvarijonaviciute, R. Barić-Rafaj, A. Horvatic, A. Muñoz-Prieto, N. Guillemin, E. Lamy, A. Tumpa, J.J. Ceron, S. Martinez-Subiela, V. Mrljak. Identification of changes in serum analytes and possible metabolic pathways associated with canine obesity-related metabolic dysfunction. The Veterinary Journal 2019; 244 doi: 10.1016/j.tvjl.2018.12.006
138
Shahinul Alam, Shah Mohammad Fahim. Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. World Journal of Hepatology 2021; 13(10): 1203-1207 doi: 10.4254/wjh.v13.i10.1203
139
Ming-Hui Yang, Wei-You Li, Ching-Fen Wu, Yi-Ching Lee, Allan Yi-Nan Chen, Yu-Chang Tyan, Yi-Ming Arthur Chen. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase. International Journal of Molecular Sciences 2022; 23(17) doi: 10.3390/ijms231710072
140
Yvonne Huber, Jörn M Schattenberg. Prävention gastroenterologischer Tumorerkrankungen. 2020;  doi: 10.1007/978-3-662-58879-6_10
141
Evan E. Lebovitz, Anh Vinh T. Nguyen, Tetsuro Sakai. Economic considerations in abdominal transplantation. Best Practice & Research Clinical Anaesthesiology 2020; 34(1) doi: 10.1016/j.bpa.2020.01.002
142
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
143
Ziyi Li, Na Yang, Liyun He, Jialu Wang, Fan Ping, Wei Li, Lingling Xu, Huabing Zhang, Yuxiu Li. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-022-00976-w
144
Acharya Balkrishna, Vivek Gohel, Rani Singh, Monali Joshi, Yash Varshney, Jyotish Srivastava, Kunal Bhattacharya, Anurag Varshney. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels. Molecules 2020; 25(20) doi: 10.3390/molecules25204849
145
Jagpreet Chhatwal, Ozden O. Dalgic, Wanyi Chen, Sumeyye Samur, Emily D. Bethea, Jade Xiao, Chin Hur, Kathleen E. Corey, Rohit Loomba. Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease. JAMA Network Open 2022; 5(9) doi: 10.1001/jamanetworkopen.2022.30426
146
Mayumi Higashi, Masahiro Tanabe, Masatoshi Yamane, Mahesh B. Keerthivasan, Hiroshi Imai, Teppei Yonezawa, Michihiro Nakamura, Katsuyoshi Ito. Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping. European Radiology 2023; 33(10) doi: 10.1007/s00330-023-10052-0
147
Mahider Shimelis Feyisa, Bruktawit Eshetu, Rahel Birhanu Arage, Besfat Berihun Erega, Ayenew Berhan, Teklehaimanot Kiros, Getaneh Mola, Ermias Bekele Enyew. Assessment of Dyslipidemia and its Associated Factors Among Non-Alcoholic Fatty Liver Disease Diagnosed Type 2 Diabetes Mellitus Patients in Adama Hospital Medical College: A Cross-Sectional Study. Clinical Medicine Insights: Endocrinology and Diabetes 2026; 19 doi: 10.1177/11795514261436946
148
Faisal M. Sanai, Abdullah Al Khathlan, Ahmad Al Fadhli, Ahmad S. Jazzar, Al Moutaz Hashim, Eid Mansour, Faisal Abaalkhail, Fuad Hasan, Hajer Al Mudaiheem, Huda Al Quraishi, Juliana Bottomley, Khalid A. Alswat, Mohammed Al Ghamdi, Mohamed Farghaly, Motaz Fathy, Nancy Awad, Omneya Mohamed, Sam Kozma, Waleed Al-Hamoudi, Ahmed Al-jedai. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait. Hepatology International 2021; 15(4) doi: 10.1007/s12072-021-10182-x
149
Amanda Chaney. Obesity and Nonalcoholic Fatty Liver Disease. Nursing Clinics of North America 2021; 56(4) doi: 10.1016/j.cnur.2021.07.009
150
Sarah A. Ashiqueali, Xiang Zhu, Denise S. Wiesenborn, Adam Gesing, Augusto Schneider, Sarah A. Noureddine, Christian G. Correa-Garcia, Michal M. Masternak, Shadab A. Siddiqi. Calorie restriction and life-extending mutation downregulate miR-34a to facilitate lipid metabolism in the liver. Experimental Gerontology 2024; 194 doi: 10.1016/j.exger.2024.112506
151
. 2019;  doi: 10.70675/0604da49z3ccdz48bbz9e5dzb2cf6b33fc93
152
Shailja C Shah, Xiangzhu Zhu, Qi Dai, Richard M Peek, Martha J Shrubsole. Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohort. The American Journal of Clinical Nutrition 2021; 113(3) doi: 10.1093/ajcn/nqaa326
153
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences. Heliyon 2024; 10(9) doi: 10.1016/j.heliyon.2024.e30387
154
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
155
Roberta Catania, Leo Jia, Maryam Haghshomar, Frank H. Miller, Amir A. Borhani. Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT. European Journal of Radiology 2024; 172 doi: 10.1016/j.ejrad.2024.111328
156
Panpan Hu. The role of novel adipokines in hepatocellular carcinoma progression: a mini review. American Journal of Cancer Research 2024; 14(11) doi: 10.62347/PZDM1736
157
Shobha Sharma, Ashok Choudhury, Venkata S. Gupta Thadikemalla, Archana Rastogi, Tapan Gandhi, Shiv K. Sarin. A Simple Laboratory-based Machine Learning Model Accurately Predicts Advanced Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease Patients. Journal of Clinical and Experimental Hepatology 2026; 16(2) doi: 10.1016/j.jceh.2025.103438
158
Fatemeh Esmaeilzadeh, Farshid Kafilzadeh, Noosha Zia Jahromi, Leila Kohan, Samaneh Zolghadri. Regulatory role of circ-UBR5 in NASH-HCC pathogenesis via interaction with disease-associated miRNA. Gene Reports 2026; 44 doi: 10.1016/j.genrep.2026.102560
159
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Alimentary Pharmacology & Therapeutics 2020; 51(11) doi: 10.1111/apt.15679
160
Maziar Jazayeri, Rasoul Zarrin, Afshin Mohammadi, Mohammad Reza Pashaei, Sajjad Ahmadpour. Effects of gluten-free diet on metabolic syndrome components and anthropometric indices in patients with nonalcoholic fatty liver disease: An open-label randomized clinical trial. Arab Journal of Gastroenterology 2026; 27(1) doi: 10.1016/j.ajg.2025.10.001
161
Yu Shi, Kai Yan Cheng, Thi Tun Thi, Yifan Wang, Yang Yang, Xiaoyun Cao, Vanna Chhay, Yujia Shen, Yuchen He, Tianyun Zhao, Yan Ting Lim, Amy Deik, Courtney Dennis, Kerry Pierce, Kevin Bullock, Martin Wabitsch, Clary B. Clish, Alexander S. Banks, Radoslaw M. Sobota, Chad A. Cowan, Haojie Yu. GPR146 in adipose tissue drives adipose-liver crosstalk and promotes hepatic steatosis in mice. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-70136-5
162
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population. Hepatology Communications 2019; 3(1) doi: 10.1002/hep4.1285
163
Thendo I. Mabuda, Nicole R. S. Sibuyi, Adewale O. Fadaka, Mervin Meyer, Abram M. Madiehe, Kwazikwakhe B. Gabuza. Targeted therapeutic strategies as alternative and sustainable treatment options for obesity-induced steatohepatitis. Reviews in Endocrine and Metabolic Disorders 2025; 26(6) doi: 10.1007/s11154-025-09980-7
164
Zaida Zakaria, Ain’ Sabreena Mohd Noh, Zaidatul Akmal Othman, Wan Syaheedah Wan Ghazali, Mahaneem Mohamed. Functional Biochemistry of Micronutrients. Advances in Biochemistry in Health and Disease 2026; 35 doi: 10.1007/978-3-032-14441-6_7
165
Luis E. Simental-Mendía, Claudia I. Gamboa-Gómez, Fernando Guerrero-Romero, Mario Simental-Mendía, Adriana Sánchez-García, Mariana Rodríguez-Ramírez. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. Advances in Experimental Medicine and Biology 2021; 1308 doi: 10.1007/978-3-030-64872-5_18
166
Yahao Wang, Yue Zhou, Zhihong Wang, Yunzhi Ni, Gerald J Prud'homme, Qinghua Wang. Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism 2025; 110(10) doi: 10.1210/clinem/dgaf336
167
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02393-9
168
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, Sachin Kumar Singh, Monica Gulati, Saurabh Sajita, Meenu Mehta, Avinash Kumar Singh, Harish Dureja, Trudi Collet, Kavita Pabreja, Dinesh Kumar Chellappan, Kamal Dua. Pathophysiology of Obesity-Induced Health Complications. 2020;  doi: 10.1007/978-3-030-35358-2_5
169
Gourdas Choudhuri, Seema R Kalel, Zubin Dev Sharma, Rinkesh Bansal . MASLD- Global prevalence, pathophysiological processes and management pathways- tackling a complex problem. Gastroenterology & Hepatology: Open access 2024; 15(4) doi: 10.15406/ghoa.2024.15.00585
170
Hongwei Yi, Deyi Xu, Xudong Wu, Fang Xu, Lin Lin, Huiping Zhou. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic InjuryviaModulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress Pathways. Antioxidants & Redox Signaling 2019; 30(17) doi: 10.1089/ars.2018.7521
171
Haoran Zhang, Jinlong Liu, Danyang Su, Zhen Bai, Yan Wu, Yuanbo Ma, Qiuju Miao, Mingyue Wang, Xiaopeng Yang, Yuki Arita. Diagnostic of fatty liver using radiomics and deep learning models on non-contrast abdominal CT. PLOS ONE 2025; 20(2) doi: 10.1371/journal.pone.0310938
172
Satsuki Sato, Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Takashi Kobayashi, Takeo Kurihashi, Shogo Takashiba, Kazu Hatanaka, Nobushiro Hamada, Toshiro Kodama, Takuma Higurashi, Masataka Taguri, Masato Yoneda, Haruki Usuda, Koichiro Wada, Atsushi Nakajima, Toshiya Morozumi, Masato Minabe. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17917-2
173
静 雷. Effect Analysis of QCT in the Diagnosis of Fatty Liver in Perimenopausal Women. Advances in Clinical Medicine 2024; 14(01) doi: 10.12677/ACM.2024.141140
174
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology. 2019;  doi: 10.1002/cphy.c190007
175
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00131
176
Saverio Nucera, Rosa Maria Bulotta, Stefano Ruga, Rosamaria Caminiti, Maria Serra, Roberto Bava, Fabio Castagna, Carmine Lupia, Mariangela Marrelli, Filomena Conforti, Giancarlo Statti, Vincenzo Mollace, Ernesto Palma. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Scientia Pharmaceutica 2023; 91(4) doi: 10.3390/scipharm91040053
177
. 2020;  doi: 10.70675/f14945bez0129z4664z9e05zf89d7c00e4a7
178
Elena S. George, Surbhi Sood, Nicole Kiss, Robin M. Daly, Amanda J. Nicoll, Stuart K. Roberts, Brenton J. Baguley. The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review. Current Oncology 2022; 30(1) doi: 10.3390/curroncol30010005
179
Francesco Andreozzi, Elettra Mancuso, Elisa Mazza, Gaia Chiara Mannino, Teresa Vanessa Fiorentino, Franco Arturi, Elena Succurro, Maria Perticone, Angela Sciacqua, Tiziana Montalcini, Arturo Pujia, Giorgio Sesti. One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastography. Diabetes, Obesity and Metabolism 2024; 26(2) doi: 10.1111/dom.15358
180
Hao Chiang, Hsu-Feng Lu, Jui-Chieh Chen, Yu-Hsin Chen, Hsi-Tai Sun, Hsiu-Chen Huang, Hsiao-Hsuan Tien, Cheng Huang, Fatima Martel. Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet‐Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in Mice. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/9519625
181
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1) doi: 10.1097/MD.0000000000034934
182
Jing Xie, Yong Shao, Jin Liu, Meilan Cui, Xiuxiao Xiao, Jingbo Gong, Binghua Xue, Qunwei Zhang, Xianwen Hu, Haifeng Duan. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77096-w
183
Kaliyaperumal Kalaiyarasi, Acharyya Sanchalika, Low Hsien Min, Yap Wei Ming, Shelat Vishalkumar, Yew Kuo Chao, Low Jee Keem, Junnarkar Sameer, Huey Cheong Wei Terence, Tan Yen Ping. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study. Medicina 2024; 60(1) doi: 10.3390/medicina60010169
184
Georgina M. Williams, Emily C. Hoedt, Kerith Duncanson, Lay Gan, Emilia Prakoso, Nicholas J. Talley, Eleanor J. Beck. Inverse associations between Mediterranean diet constituents and the gut microbiota in metabolic-associated steatotic liver disease (MASLD): a case-control study. Nutrition & Metabolism 2025; 23(1) doi: 10.1186/s12986-025-00939-8
185
Maryam Chegeni, Sairan Nili, Mehdi Darabi, Elham Gheysvandi, Razieh Zahedi, Elham Sharifian, Hamid Reza Shoraka, Mohammad Rostamkhani, Leili Abedi Gheshlaghi. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis. Journal of Education and Health Promotion 2023; 12(1) doi: 10.4103/jehp.jehp_1056_22
186
Bevin E. Blake, Colette N. Miller, Helen Nguyen, Vesna A. Chappell, Trina P. Phan, Dhiral P. Phadke, Michele R. Balik-Meisner, Deepak Mav, Ruchir R. Shah, Suzanne E. Fenton. Transcriptional pathways linked to fetal and maternal hepatic dysfunction caused by gestational exposure to perfluorooctanoic acid (PFOA) or hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) in CD-1 mice. Ecotoxicology and Environmental Safety 2022; 248 doi: 10.1016/j.ecoenv.2022.114314
187
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H. Birkebæk, Jan Frystyk. Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European Journal of Pediatrics 2022; 182(2) doi: 10.1007/s00431-022-04731-1
188
Yii-Shiuan Lee, Shih-Hsi Song, Tzee-Chung Wu, Shang-Liang Wu, Ching-Feng Huang. Correlation of hepatic transient elastography measurements and abdominal adiposity in children: A cross-sectional study. Pediatrics & Neonatology 2023; 64(6) doi: 10.1016/j.pedneo.2022.12.018
189
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in mice. World Chinese Journal of Digestology 2020; 28(13) doi: 10.11569/wcjd.v28.i13.519
Abstract(0) |  Core Tip(0) |  Full Article(HTML)(0) | Times Cited (2) | Total Visits (0) | Open
190
Yang Zou, Ling Zhong, Chong Hu, Mingchun Zhong, Nan Peng, Guotai Sheng. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01457-1
191
Gavin Low, Craig Ferguson, Stephanie Locas, Wendy Tu, Florin Manolea, Medica Sam, Mitchell P. Wilson. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver “Triple Screen”. Abdominal Radiology 2023; 48(6) doi: 10.1007/s00261-023-03887-0
192
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
193
Winnie Tatiana Bekolo Nga, Martine Claude Etoa, Bidjogo Gwet Marina, Servais A. F. Eloumou Bagnaka, Antonin Wilson Ndjitoyap Ndam, Agnès Malongue, Mathurin Kowo, Christian Tzeuton, Dominique Noah Noah, Oudou Njoya, Firmin Ankouane Andoulo, Luma H. Namme. Prevalence and Factors Associated with Hepatic Steatosis in Patients with Metabolic Syndrome in Cameroon: Cases of 4 Reference Hospitals. Open Journal of Gastroenterology 2023; 13(03) doi: 10.4236/ojgas.2023.133011
194
Claudia Luckert, Albert Braeuning, Georges de Sousa, Sigrid Durinck, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad A. C. M. Peijnenburg, Roger Rahmani, Andreja Rajkovic, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Alfonso Lampen. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole. Chemical Research in Toxicology 2018; 31(8) doi: 10.1021/acs.chemrestox.8b00112
195
Ioan Sporea, Ruxandra Mare, Alina Popescu, Silviu Nistorescu, Victor Baldea, Roxana Sirli, Adina Braha, Alexandra Sima, Romulus Timar, Raluca Lupusoru. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. Journal of Clinical Medicine 2020; 9(4) doi: 10.3390/jcm9041032
196
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). Pharmacology Research & Perspectives 2019; 7(3) doi: 10.1002/prp2.485
197
Thomas Schreiter, Robert K. Gieseler, Ramiro Vílchez-Vargas, Ruy Jauregui, Jan-Peter Sowa, Susanne Klein-Scory, Ruth Broering, Roland S. Croner, Jürgen W. Treckmann, Alexander Link, Ali Canbay. Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed ‘Aging Cascade’. Pharmaceutics 2021; 13(12) doi: 10.3390/pharmaceutics13122009
198
Joseph Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice. International Journal of Molecular Sciences 2019; 20(9) doi: 10.3390/ijms20092222
199
Andrea Gonzalez, Camila Huerta-Salgado, Josué Orozco-Aguilar, Francisco Aguirre, Franco Tacchi, Felipe Simon, Claudio Cabello-Verrugio, Ana Cipak Gasparovic. Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/1617805
200
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
201
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
202
Laura Valenzuela-Vallejo, Despina Sanoudou, Christos S. Mantzoros. Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease. Journal of Personalized Medicine 2023; 13(5) doi: 10.3390/jpm13050830
203
Ciniso Sylvester Shabangu, Jee-Fu Huang, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. International Journal of Molecular Sciences 2020; 21(10) doi: 10.3390/ijms21103732
204
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
205
Gen Yamada, Yasuhiro Hagiwara, Takeshi Kimura, Yoshinori Takeuchi, Koji Oba, Katsunori Masuda, Yutaka Matsuyama. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals. American Journal of Gastroenterology 2021; 116(4) doi: 10.14309/ajg.0000000000001030
206
Hideki Fujii, Haruna Doi, Tetsuhisa Ko, Taito Fukuma, Toru Kadono, Kohei Asaeda, Reo Kobayashi, Takahiro Nakano, Toshifumi Doi, Yoshikazu Nakatsugawa, Shinya Yamada, Takeshi Nishimura, Naoya Tomatsuri, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Etsuko Kishimoto, Nami Nakabe, Takatomo Shima. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01369-x
207
Tokunbo Ajayi, Gina Moon, Sixia Chen, Steven Pan, Abdul Oseini, Courtney Houchen. Surging Liver Transplantation for Nonalcoholic Steatohepatitis from 2000–2022: A National Database Study. Southern Medical Journal 2024; 117(6) doi: 10.14423/SMJ.0000000000001699
208
Scott A. Reisman, Deborah A. Ferguson, Chun‐Yue I. Lee, Joel W. Proksch. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. Journal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22526
209
Sajad Abolfazli, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar. A Golden Shield: The Protective Role of Curcumin against Liver Fibrosis. Current Medicinal Chemistry 2025; 32(10) doi: 10.2174/0929867331666230821095329
210
Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin. Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. PLOS ONE 2018; 13(12) doi: 10.1371/journal.pone.0208798
211
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver disease. Indian Journal of Physiology and Pharmacology 2021; 65 doi: 10.25259/IJPP_406_2020
212
Sex different effect of antibiotic and probiotic treatment on intestinal microbiota composition in chemically induced liver injury rats. Genomics 2023; 115(4) doi: 10.1016/j.ygeno.2023.110647
213
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
214
Celso Pereira Batista Sousa-Filho, Victoria Silva, Anaysa Paola Bolin, Andrea Livia Silva Rocha, Rosemari Otton. Green tea actions on miRNAs expression – An update. Chemico-Biological Interactions 2023; 378 doi: 10.1016/j.cbi.2023.110465
215
Andrea C. Postmus, Ines Sturmlechner, Johan W. Jonker, Jan M. van Deursen, Bart van de Sluis, Janine K. Kruit. Senescent cells in the development of cardiometabolic disease. Current Opinion in Lipidology 2019; 30(3) doi: 10.1097/MOL.0000000000000602
216
Sangmin You, Ai-Min Cui, Syed F. Hashmi, Xinmu Zhang, Christina Nadolny, Yuan Chen, Qiwen Chen, Xin Bush, Zachary Hurd, Winifer Ali, Gang Qin, Ruitang Deng. Dysregulation of bile acids increases the risk for preterm birth in pregnant women. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-15923-4
217
Masashi Hirooka, Sadanobu Ogawa, Yohei Koizumi, Yuichi Yoshida, Tatsuya Goto, Satoshi Yasuda, Masahiro Yamahira, Tsutomu Tamai, Ryoko Kuromatsu, Toshihisa Matsuzaki, Tomoyuki Suehiro, Yoshihiro Kamada, Yoshio Sumida, Yoichi Hiasa, Hidenori Toyoda, Takashi Kumada. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study. Journal of Gastroenterology 2024; 59(6) doi: 10.1007/s00535-024-02096-w
218
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. Biomedicine & Pharmacotherapy 2019; 117 doi: 10.1016/j.biopha.2019.109158
219
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
220
Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, Mingchun Zhong, Yang Zou. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01479-9
221
Reza Etminani, Zahara Abdul Manaf, Suzana Shahar, Leila Azadbakht, Peyman Adibi. Predictors of Nonalcoholic Fatty Liver Disease Among Middle-Aged Iranians. International Journal of Preventive Medicine 2020; 11(1) doi: 10.4103/ijpvm.IJPVM_274_19
222
Alexa M. Giammarino, He Qiu, Kishen Bulsara, Sabrina Khan, Yu Jiang, Ben L. Da, David E. Bernstein, Sanjaya K. Satapathy. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatology Communications 2022; 6(3) doi: 10.1002/hep4.1831
223
Konstantinos Damiris, Zaid H Tafesh, Nikolaos Pyrsopoulos. Efficacy and safety of anti-hepatic fibrosis drugs. World Journal of Gastroenterology 2020; 26(41): 6304-6321 doi: 10.3748/wjg.v26.i41.6304
224
Qi Chen, Xiaohong Wang, Jieyu Peng, Shu Huang, Rui Luo, Shiqi Li, Jinxi Zhao, Huan Xu, Ping Wang, Xiaomin Shi, Wei Zhang, Lei Shi, Yan Peng, Xiaowei Tang. The burden of digestive diseases in Asian countries and territories from 1990 to 2019: an analysis for the Global Burden of Disease 2019 study. npj Gut and Liver 2025; 2(1) doi: 10.1038/s44355-025-00019-x
225
Kristin M Hirahatake, Richard S Bruno, Bradley W Bolling, Christopher Blesso, Lacy M Alexander, Sean H Adams. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health. Advances in Nutrition 2020; 11(2) doi: 10.1093/advances/nmz105
226
Yan Yun SHU, Li Lin HU, Jin YE, Ling YANG, Yu JIN. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier. Life Sciences 2024; 357 doi: 10.1016/j.lfs.2024.123095
227
Yiyu Lin, Yanglong Liu, Jianshen Liu, Jianxing Wu, Kunhua Wei, Jiao Guo, Zhengquan Su. Bidirectional regulation of free fatty acid receptors and non-alcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2026; 149 doi: 10.1016/j.jnutbio.2025.110180
228
Shang-Yu Chai, Ru-Ya Zhang, Gail Fernandes, Yi-Man Zheng, Lai Wei. Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis. World Journal of Gastroenterology 2025; 31(46): 113608 doi: 10.3748/wjg.v31.i46.113608
229
Maela Duclos, Zeineb Marzougui, Mariam Saleh, Anne Corlu, Julie Massart, Pierre‐Jean Ferron. Multi‐Cellular Human Liver Organoids for Modeling Metabolic Dysfunction–Associated Steatotic Liver Disease and Drug‐Induced Liver Injury. Current Protocols 2026; 6(1) doi: 10.1002/cpz1.70294
230
Felicia Darii, Olga Tagadiuc. Povara bolii ficatului steatozic. Akademos 2024; (2(73)) doi: 10.52673/18570461.24.2-73.09
231
Bohan Luo, Ling Guo, Wenjia Di. PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients. Renal Failure 2025; 47(1) doi: 10.1080/0886022X.2025.2604881
232
Dazhang Deng, Yutong Xie, Ya Wang, Wanhan Song, Yuguo Liu, Bin Liu, Honghui Guo. Construction and validation of a nomogram for detecting chronic kidney disease in patients with nonalcoholic fatty liver disease: Insights from the NHANES database. Clinics 2025; 80 doi: 10.1016/j.clinsp.2025.100686
233
Rehab F. Abdel-Rahman. Non-alcoholic fatty liver disease. Asian Pacific Journal of Tropical Biomedicine 2022; 12(3) doi: 10.4103/2221-1691.338919
234
Christian L. Horn, Anvi C. Ta, Nadege T. Gunn. Current and Emerging Treatments for Non-alcoholic Steatohepatitis. Current Hepatology Reports 2020; 19(4) doi: 10.1007/s11901-020-00540-y
235
Agata Muzsik-Kazimierska, Artur Szwengiel, Grzegorz Nikrandt, Agata Chmurzynska. Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women. Nutrition Research 2022; 101 doi: 10.1016/j.nutres.2022.02.004
236
Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2019; 17(10) doi: 10.1016/j.cgh.2019.01.001
237
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147716
238
Xueyan Gu, Xiaocui Ma, Limin Mo, Qiyu Wang. The Role of Exercise Intensity on Fatty Liver in Rats. Chinese Journal of Physiology 2022; 65(6) doi: 10.4103/0304-4920.365461
239
Imran Ali, Hasan M. Khan, Muhammad Naveed Akram, Yang-Fang Chen, Mujahid Mustaqeem, Tawfik A. Saleh, Muhammad Ahmad, Imran Sadiq, Nimra Lateef. Zn/Ba nanoparticles doping effect on surface interface, Morphology, and dielectric elucidation of spinel ferrites. Surfaces and Interfaces 2023; 38 doi: 10.1016/j.surfin.2023.102862
240
Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai. Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility Study. Ultrasonic Imaging 2020; 42(4-5) doi: 10.1177/0161734620921532
241
Erika R. Bjørnå, Martine T. Engelsen, Hashem B. El-Serag, Eivind Ness-Jensen. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scandinavian Journal of Gastroenterology 2023; 58(5) doi: 10.1080/00365521.2022.2139633
242
Shereen Abdel Alem, Yasser Fouad, Mohamed AbdAllah, Dina Attia, Inas Kamal, Ebada Said, Ahmed Gomaa, Sherief M. Abd-Elsalam, Yasmine Gaber. Hepatologists’ Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(12) doi: 10.2174/1871530323666221028154159
243
Ke Xu, Mingming Shi, Weiteng Zhang, Yiyi Shi, Qiantong Dong, Xian Shen, Xiaolei Chen, Ji Lin. Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.655343
244
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169 doi: 10.1016/j.prostaglandins.2023.106766
245
Chiranjeevi Gadiparthi, Moshe Spatz, Simi Greenberg, Umair Iqbal, Sowjanya Kanna, Sanjaya K Satapathy, Arkady Broder, Aijaz Ahmed. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. Journal of Clinical and Translational Hepatology 2020; 8(2) doi: 10.14218/JCTH.2020.00014
246
Manuel Romero-Gomez, Nandita Kachru, Meritxell Ascanio Zamorano, Josep Darba, Sanatan Shreay. Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain. Medicine 2020; 99(50) doi: 10.1097/MD.0000000000023506
247
Emilio Balbuena, Junrui Cheng, Abdulkerim Eroglu. Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.987103
248
Kwazi Gabuza, Thendo I. Mabuda, Oelfah Patel, Noxolo Khuboni, Ruzayda van Aarde, Sylvia Riedel, Nonhlakanipho F. Sangweni, Shantal Windvogel, Rabia Johnson, Christo J. F. Muller, Andrea Mastinu. Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD. PLOS ONE 2024; 19(4) doi: 10.1371/journal.pone.0297572
249
Gourdas Choudhuri, Saumin Shah, Anand Kulkarni, Nitin Jagtap, Pratyusha Gaonkar, Akshay Desai, Charles Adhav. Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions. Cureus 2023;  doi: 10.7759/cureus.42852
250
Jotham Josephat Kimondo, Ramadhan Rashid Said, Jun Wu, Chao Tian, Zhe Wu, Pawel Klosowski. Mechanical rheological model on the assessment of elasticity and viscosity in tissue inflammation: A systematic review. PLOS ONE 2024; 19(7) doi: 10.1371/journal.pone.0307113
251
Armin Ebrahimzadeh, Anahita Ebrahimzadeh, Sara Fooladshekan, Shokouh Mohseni, Abbas Mohtashamian, Siavash Babajafari, Zahra Sohrabi. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta‐analysis of randomized clinical trials. Food Science & Nutrition 2025; 13(1) doi: 10.1002/fsn3.4144
252
Zaida Zakaria, Zaidatul Akmal Othman, Joseph Bagi Suleiman, Nur Asyilla Che Jalil, Wan Syaheedah Wan Ghazali, Victor Udo Nna, Mahaneem Mohamed. Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Antioxidants 2021; 10(12) doi: 10.3390/antiox10122031
253
Chih-Hao Lin, Ming-Chih Ho, Po-Chu Lee, Po-Jen Yang, Yung-Ming Jeng, Jia-Huei Tsai, Chiung-Nien Chen, Argon Chen. Clinical performance of ultrasonic backscatter parametric and nonparametric statistics in detecting early hepatic steatosis. Ultrasonics 2024; 142 doi: 10.1016/j.ultras.2024.107391
254
Pinar Yilmaz, Louise J. M. Alferink, Lotte G. M. Cremers, Sarwa D. Murad, Wiro J. Niessen, M. Arfan Ikram, Meike W. Vernooij. Subclinical liver traits are associated with structural and hemodynamic brain imaging markers. Liver International 2023; 43(6) doi: 10.1111/liv.15549
255
Min Zhang, Nan Yu, Chuangbo Yang, Haifeng Duan, Zhanli Ren. Quantifying non-alcoholic fatty liver: liver–spleen CT ratio and fat concentration in dual-energy spectral CT. Die Radiologie 2026;  doi: 10.1007/s00117-026-01562-1
256
Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu. Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01763-2
257
Joana L. Fernandes, Fátima O. Martins, Elena Olea, Jesus Prieto-Lloret, Patrícia C. Braga, Joana F. Sacramento, Catarina O. Sequeira, Ana P. Negrinho, Sofia A. Pereira, Marco G. Alves, Asunción Rocher, Silvia V. Conde. Chronic Intermittent Hypoxia-Induced Dysmetabolism Is Associated with Hepatic Oxidative Stress, Mitochondrial Dysfunction and Inflammation. Antioxidants 2023; 12(11) doi: 10.3390/antiox12111910
258
. 2019;  doi: 10.70675/7f0f7d18z2e64z471fz93b7z12498efca3c8
259
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. Gastroenterology Clinics of North America 2020; 49(1) doi: 10.1016/j.gtc.2019.09.005
260
Jiahui Li, Xin Lu, Zheng Zhu, Kyle J. Kalutkiewicz, Taofic Mounajjed, Terry M. Therneau, Sudhakar K. Venkatesh, Yi Sui, Kevin J. Glaser, Safa Hoodeshenas, Armando Manduca, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology 2023; 78(4) doi: 10.1097/HEP.0000000000000417
261
Галина Корнован , Володимир Синенко , Лариса Колотвіна , Яна Бажора , Дарʼя Лагода , Вероніка Назарян , Ганна Амірова , Олена Паслар . КОМОРБІДНА ПАТОЛОГІЯ ПЕЧІНКИ У ПАЦІЄНТІВ, ЯКІ ЖИВУТЬ З ОЖИРІННЯМ. Grail of Science 2022; (17) doi: 10.36074/grail-of-science.22.07.2022.073
262
Xiaomin Hua, Heping Zhang, Wenru Yang, Guotao Liu, Suhua Zhang, Yingcui Wang. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1176019
263
Adarsh Raja, Raja Subhash Sagar, Sadia Saeed, Amna Zia ul haq, Owais Khan, Parshant Dileep Bhimani, Sandesh Raja, Fnu Deepak, Muhammad Ahmed, Muhammad Ashir Shafique, Muhammad Saqlain Mustafa, Muhammad Sohaib Asghar, Varsha Sharma. Safety and efficacy of resmetirom in the treatment of patients with non-alcoholic steatohepatitis and liver fibrosis: a systematic review and meta-analysis. Annals of Medicine & Surgery 2024; 86(7) doi: 10.1097/MS9.0000000000002195
264
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Giovanni Targher. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?. Digestive and Liver Disease 2019; 51(4) doi: 10.1016/j.dld.2018.12.014
265
Miaoting Yang, Zhijuan Chen, Shijian Xiang, Fan Xia, Waijiao Tang, Xiaorui Yao, Benjie Zhou. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03164-3
266
Ji-Youn Kim, Yong-Moon Park, Gyu-Na Lee, Hyun Chul Song, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko, Houkai Li. Association between toothbrushing and non-alcoholic fatty liver disease. PLOS ONE 2021; 16(5) doi: 10.1371/journal.pone.0243686
267
Chang-hua Zhang, Bu-gao Zhou, Jun-qing Sheng, Yang Chen, Ying-qian Cao, Chen Chen. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacological Research 2020; 159 doi: 10.1016/j.phrs.2020.104984
268
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
269
Dimitrios Tsilingiris, Evangelia Tzeravini, Chrysi Koliaki, Maria Dalamaga, Alexander Kokkinos. The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. Current Obesity Reports 2021; 10(3) doi: 10.1007/s13679-021-00434-0
270
Rui Gao, Xiaobo Zhang, Zhen Zhou, Jiayi Sun, Xuehua Tang, Jialiang Li, Xin Zhou, Tao Shen, Zhaoqi Dong. Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking. Disease Markers 2022; 2022 doi: 10.1155/2022/7251450
271
Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa. Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PLOS ONE 2024; 19(4) doi: 10.1371/journal.pone.0299507
272
Mi-Bo Kim, Tho X. Pham, Molly vanLuling, Victoria Kostour, Hyunju Kang, Olivia Corvino, Hyungryun Jang, William Odell, Minkyung Bae, Young-Ki Park, Ji-Young Lee. Nicotinamide riboside supplementation exerts an anti–obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice. The Journal of Nutritional Biochemistry 2022; 107 doi: 10.1016/j.jnutbio.2022.109058
273
Grace E. Shryack, Alexa A. Krause, Simone Hernandez Ruano, Laura C. Schulz, Kathleen A. Pennington, R. Scott Rector. A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1498764
274
Graciela K. Krolow, Eduardo Garcia, Fabiola Schoor, Fernanda B.S. Araujo, Gabriela P. Coral. Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2021; 33(8) doi: 10.1097/MEG.0000000000001920
275
Maria Wallert, Lisa Börmel, Stefan Lorkowski. Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?. Molecular Nutrition & Food Research 2021; 65(1) doi: 10.1002/mnfr.202000097
276
Ioan Sporea, Raluca Lupușoru, Roxana Șirli. Elastography - Applications in Clinical Medicine. 2022;  doi: 10.5772/intechopen.102363
277
Luis Cano, Fabien Foucher, Orlando Musso. Geographic diversity of human liver cancers mirrors global social inequalities. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1565692
278
V.S. Rakhmetova. STEATOTIC LIVER DISEASE: THE IMPACT OF TEA AND COFFEE CONSUMPTION. LITERATURE REVIEW . Наука и здравоохранение 2025; (5(27)) doi: 10.34689/SH.2025.27.5.030
279
Yitong Huang, Di Qiu, Feng Xuan. Global burden, trends, and inequalities in cancer and subtypes attributable to high BMI among older adults, 1990–2021: a secondary analysis of the global burden of disease study 2021. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1683893
280
Neil R. Chappell, Beth Zhou, Pardis Hosseinzadeh, Amy Schutt, William E. Gibbons, Chellakkan S. Blesson. Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome. F&S Science 2021; 2(1) doi: 10.1016/j.xfss.2020.12.001
281
Jing Guo, Ingolf Sack, Stephan Rodrigo Marticorena Garcia. Liver Elastography. 2020;  doi: 10.1007/978-3-030-40542-7_6
282
Faridoddin Mirshahi, Hussein F. Aqbi, Madison Isbell, Saeed H. Manjili, Chunqing Guo, Mulugeta Saneshaw, Dipankar Bandyopadhyay, Mikhail Dozmorov, Archit Khosla, Katy Wack, Oscar M. Carrasco-Zevallos, Michael O. Idowu, Xiang-Yang Wang, Arun J. Sanyal, Masoud H. Manjili. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. Cell Reports 2022; 38(9) doi: 10.1016/j.celrep.2022.110454
283
Emilio Molina‐Molina, Guilherme Eustaquio. Furtado, John G. Jones, Piero Portincasa, Ana Vieira‐Pedrosa, Ana Maria Teixeira, Marcelo Paes Barros, André Luís Lacerda Bachi, Vilma A. Sardão. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13731
284
Laura Valenzuela-Vallejo, Christos S. Mantzoros. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). Metabolism 2022; 134 doi: 10.1016/j.metabol.2022.155246
285
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary Pharmacology & Therapeutics 2022; 56(6) doi: 10.1111/apt.17158
286
Hanieh Barghchi, Narges Milkarizi, Saba Belyani, Andisheh Norouzian Ostad, Vahid Reza Askari, Farnood Rajabzadeh, Ladan Goshayeshi, Seyede Yegane Ghelichi Kheyrabadi, Maryam Razavidarmian, Zahra Dehnavi, Seyyed Reza Sobhani, Mohsen Nematy. Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial. Nutrition Journal 2023; 22(1) doi: 10.1186/s12937-023-00869-2
287
Alexandra Lasch, Philip Marx-Stoelting, Albert Braeuning, Dajana Lichtenstein. More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells. Archives of Toxicology 2021; 95(4) doi: 10.1007/s00204-021-02997-2
288
Simin Fan, Zunming Zhou, Jintong Ye, Yanfang Li, Keer Huang, Xuehong Ke, Waseem Hassan. Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/9739032
289
Jaime Hui Xian Lin, Veeraraghavan Meyyur Aravamudan. Metabolic associated fatty liver disease and COVID-19: a double whammy?. Singapore Medical Journal 2022; 63(9) doi: 10.11622/smedj.2020141
290
Dongxu Wang, Bing He. Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022;  doi: 10.2147/DMSO.S362424
291
Yong Jun Choi, Jooheon Park, Han-Ik Cho, Myung Geun Shin, Eun-Hee Nah. Metabolic Dysfunction-Associated Steatotic Liver Disease in the Korean General Population: Epidemiology, Risk Factors, and Non-Invasive Screening. Metabolites 2025; 15(5) doi: 10.3390/metabo15050299
292
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali, Behnaz Abiri. A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01502-w
293
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. Indian Journal of Gastroenterology 2020; 39(1) doi: 10.1007/s12664-020-01020-3
294
Maxime Tremblay, Nicolas Perrot, Nooshin Ghodsian, Émilie Gobeil, Christian Couture, Patricia L Mitchell, Sébastien Thériault, Benoit J Arsenault. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism 2021; 106(8) doi: 10.1210/clinem/dgab144
295
Yuting Ma, Chengxia Kan, Hongyan Qiu, Yongping Liu, Ningning Hou, Fang Han, Junfeng Shi, Xiaodong Sun. Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.793586
296
Olfa Khalifa, Neyla S. AL-Akl, Khaoula Errafii, Abdelilah Arredouani. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06143-5
297
Andrew Yang, Melinda Nguyen, Irene Ju, Anthony Brancatisano, Brendan Ryan, David van der Poorten. Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93294-6
298
Mohamed Elfaal, Alanna Supersad, Craig Ferguson, Stephanie Locas, Florin Manolea, Mitchell P Wilson, Medica Sam, Wendy Tu, Gavin Low. Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis. World Journal of Radiology 2023; 15(10): 293-303 doi: 10.4329/wjr.v15.i10.293
299
Pichamol Jirapinyo, Thomas R. McCarty, Russell D. Dolan, Raj Shah, Christopher C. Thompson. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(3) doi: 10.1016/j.cgh.2021.03.017
300
Hee Yeon Kim, Mary E. Rinella. Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment. Clinical and Molecular Hepatology 2025; 31(3) doi: 10.3350/cmh.2025.0083
301
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(7) doi: 10.1080/17474124.2019.1617696
302
Leen Heyens, Hanna Kenjic, Pieter Dagnelie, Casper Schalkwijk, Coen Stehouwer, Steven Meex, Jeroen Kooman, Otto Bekers, Marleen van Greevenbroek, Hans Savelberg, Geert Robaeys, Bastiaan de Galan, Annemarie Koster, Martien van Dongen, Simone Eussen, Ger Koek. Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study. BMJ Open Gastroenterology 2024; 11(1) doi: 10.1136/bmjgast-2024-001466
303
Seonghae Yoon, Heechan Lee, Sang‐Chun Ji, Seo Hyun Yoon, Joo‐Youn Cho, Jae‐Yong Chung. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. Clinical Pharmacology in Drug Development 2021; 10(1) doi: 10.1002/cpdd.790
304
Muhammad Sohaib Asghar, Maira Hassan, Uzma Rasheed, Syed Jawad Haider Kazmi, Noman A Khan, Faran Khalid, Ayesha Anum, Saira Anwar. Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease. Cureus 2020;  doi: 10.7759/cureus.11146
305
Kiarash Riazi, Hassan Azhari, Jacob H Charette, Fox E Underwood, James A King, Elnaz Ehteshami Afshar, Mark G Swain, Stephen E Congly, Gilaad G Kaplan, Abdel-Aziz Shaheen. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2022; 7(9) doi: 10.1016/S2468-1253(22)00165-0
306
Razk Abdalgwad, Mohammed F. Rafey, Siobhan Foy, Micheál Newell, Colin Davenport, Derek T. O'Keeffe, Francis M. Finucane. Long-Term Changes in Weight in Patients With Severe and Complicated Obesity After Completion of a Milk-Based Meal Replacement Programme. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.551068
307
Yicheng Jiang, Yu Wang, Shuai Chen, Zhixin Liu, Haojun Yang, Yuwen Jiao, Liming Tang, Guangtao Xu. Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms. Disease Markers 2023; 2023 doi: 10.1155/2023/2970429
308
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology. 2020;  doi: 10.1007/978-3-030-48767-6_6
309
Eric J. Hyzny, Ernest G. Chan, Matthew Morrell, Takashi Harano, Pablo G. Sanchez. A review of liver dysfunction in the lung transplant patient. Clinical Transplantation 2021; 35(8) doi: 10.1111/ctr.14344
310
MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910604
311
Yuqing Cai, Jia Chen, Xiaoyu Deng, Biying Wang, Jiefeng Huang, Ningfang Lian. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients. BMC Pulmonary Medicine 2024; 24(1) doi: 10.1186/s12890-024-03166-8
312
Kader Torbator, Stephanie Poo, Taif Al-Rubaye, Leah Mapara, Sungeeta Punjabi, Ali Al-Rubaye, Laith Alrubaiy. Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project. Cureus 2022;  doi: 10.7759/cureus.24714
313
Mohamed I. Elsaid, You Li, Carolyn Catalano, Carlos D. Minacapelli, Kapil Gupta, Vinod K. Rustgi. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States. PharmacoEconomics - Open 2021; 5(1) doi: 10.1007/s41669-020-00229-4
314
Faridoddin mirshahi, Hussein Aqbi, Madison Isbell, Saeed Manjili, Chunqing Guo, Mulugeta Saneshaw, Dipankar Bandyopadhyay, Mikhail Dozmorov, Archit Khosla, Katy Wack, Oscar Carrasco-Zevallos, Michael Idowu, Xiang-Yang Wang, Arun Sanyal, Masoud Manjili. . 2021;  doi: 10.2139/ssrn.3927425
315
Hande Erman, Engin Beydogan, Seher Irem Cetin, Banu Boyuk. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Mediators of Inflammation 2020; 2020 doi: 10.1155/2020/3534042
316
Lu Liu, Sen Sun, Xiaohua Li. A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3. Molecular and Cellular Probes 2023; 71 doi: 10.1016/j.mcp.2023.101926
317
Hyunji Lee, Heejin Bae, Ja Kyung Yoon, June Park, Yong Eun Chung. Comparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification. Investigative Magnetic Resonance Imaging 2024; 28(1) doi: 10.13104/imri.2023.0020
318
Sarayu A. Pai, Renuka P. Munshi, Falguni H. Panchal, Ila-Shruti Gaur, Snehal N. Mestry, Malvika S. Gursahani, Archana R. Juvekar. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomedicine & Pharmacotherapy 2019; 111 doi: 10.1016/j.biopha.2018.12.139
319
Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Letters 2021; 595(19) doi: 10.1002/1873-3468.14193
320
Yu Chung Chooi, Faidon Magkos, Jadegoud Yaligar, Navin Michael, Suresh Anand Sadananthan, Yeshe Manuel Kway, S. Sendhil Velan, Kevin Junliang Lim, Xianning Lai, Long Hui Wong, Yap Seng Chong, Evelyn Xiu Ling Loo, Johan G. Eriksson. Adherence to a “MediterrAsian” diet is associated with weight loss-independent improvements in liver fat and lipid profile, but not glucoregulation or inflammation: secondary analysis of a randomized controlled trial. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1623612
321
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115571
322
Yingfei Xi, Hongshan Li. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy 2020; 121 doi: 10.1016/j.biopha.2019.109609
323
Yang Zou, Ling Zhong, Chong Hu, Guotai Sheng. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01419-z
324
Amin Ullah, Ahmad Ud Din, Wen Ding, Zheng Shi, Sadaf Pervaz, Bairong Shen. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Reviews in Endocrine and Metabolic Disorders 2023; 24(4) doi: 10.1007/s11154-023-09800-w
325
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos, Vijay Hegde. Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.721858
326
Xiang Li, Xiaodan Yin, Jun Xu, Lei Geng. Application of Steatotic Donor Livers in Liver Transplantation. The Korean Journal of Gastroenterology 2025; 85(2) doi: 10.4166/kjg.2025.013
327
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. American Journal of Gastroenterology 2020; 115(4) doi: 10.14309/ajg.0000000000000484
328
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9) doi: 10.1097/JCMA.0000000000000585
329
Rajesh Krithika, Ramtej Jayaram Verma. Hypolipidemic and Hypoglycemic Effects of Hydroalcoholic Extract of Solanum nigrum Linn. in CCl4-induced Hepatotoxicity in Mice. Toxicology and Environmental Health Sciences 2018; 10(5) doi: 10.1007/s13530-018-0375-z
330
Jacqueline Córdova-Gallardo, Andrew P. Keaveny, Xingshun Qi, Nahum Méndez-Sánchez. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems. European Journal of Gastroenterology & Hepatology 2021; 33(1S) doi: 10.1097/MEG.0000000000002335
331
Vahid Sheikhi, Zahra Heidari. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Advanced Biomedical Research 2022; 11(1) doi: 10.4103/abr.abr_15_21
332
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?. Abdominal Radiology 2020; 45(11) doi: 10.1007/s00261-020-02783-1
333
Masafumi Kuzuya, Rong Qian Shi, Madoka Yanagawa, Kazuhisa Watanabe, Satoshi Samizo, Ryota Ando. Long‐lived Werner syndrome patient autopsy report: The presence of liver cirrhosis. Geriatrics & Gerontology International 2021; 21(5) doi: 10.1111/ggi.14149
334
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021;  doi: 10.7759/cureus.17321
335
M. A. Livzan, T. S. Krolevets, M. I. Syrovenko. Liver fibrosis in a comorbid patient with metabolicassociated (non-alcoholic) fatty liver disease (MAFLD-NAFLD) and cardiovascular disease. Experimental and Clinical Gastroenterology 2023; (4) doi: 10.31146/1682-8658-ecg-212-4-133-139
336
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11) doi: 10.1016/j.medcle.2022.05.009
337
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Pharmacological Research 2018; 137 doi: 10.1016/j.phrs.2018.09.025
338
Kanami Ohshima, Emika Hara, Mio Takimoto, Yidan Bai, Mai Hirata, Wen Zeng, Suzuka Uomoto, Mai Todoroki, Mio Kobayashi, Takuma Kozono, Tetsuhito Kigata, Makoto Shibutani, Toshinori Yoshida. Peroxisome Proliferator Activator α Agonist Clofibrate Induces Pexophagy in Coconut Oil-Based High-Fat Diet-Fed Rats. Biology 2024; 13(12) doi: 10.3390/biology13121027
339
Annah P. Baykal, Elizabeth J. Parks, Robert Shamburek, Majid M. Syed-Abdul, Shaji Chacko, Elaine Cochran, Megan Startzell, Ahmed M. Gharib, Ronald Ouwerkerk, Khaled Z. Abd-Elmoniem, Peter J. Walter, Mary Walter, Ranganath Muniyappa, Stephanie T. Chung, Rebecca J. Brown. Leptin decreases de novo lipogenesis in patients with lipodystrophy. JCI Insight 2020; 5(14) doi: 10.1172/jci.insight.137180
340
Bin Yu, Yuxin Zhu, Yue Tong, Haomeng Zhang, Xiuli Lu, Hui He, Shuang Liang, Fuyu Xue, Haipeng Huang. The efficacy and safety of acupuncture compared to Western medicine in patients with nonalcoholic fatty liver disease: A systematic review and meta‐analysis. Precision Medical Sciences 2026; 15(3) doi: 10.1002/prm2.70040
341
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. Cancers 2021; 13(14) doi: 10.3390/cancers13143473
342
Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1057769
343
Ioannis I. Moustakas, Angeliki Katsarou, Aigli-Ioanna Legaki, Iryna Pyrina, Konstantinos Ntostoglou, Alkistis-Maria Papatheodoridi, Bettina Gercken, Ioannis S. Pateras, Vassilis G. Gorgoulis, Michael Koutsilieris, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. International Journal of Molecular Sciences 2021; 22(7) doi: 10.3390/ijms22073446
344
Nirupama Esther Jerome, Nancy E. Edwards, Qinglan (Priscilla) Ding. Impact of Mediterranean Dietary Education on Symptoms for Adults at Risk for Nonalcoholic Fatty Liver Disease. Gastroenterology Nursing 2023; 46(5) doi: 10.1097/SGA.0000000000000753
345
Amy W Rachfal, Struan FA Grant, Stanley S Schwartz. The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. International Journal of General Medicine 2021;  doi: 10.2147/IJGM.S305156
346
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials . Cureus 2020;  doi: 10.7759/cureus.9018
347
Minjuan Ma, Rui Duan, Hong Zhong, Tingming Liang, Li Guo. The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. Journal of Immunology Research 2019; 2019 doi: 10.1155/2019/3954890
348
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6) doi: 10.1007/s40290-019-00305-z
349
Teresa Vanessa Fiorentino, Francesca De Vito, Evelina Suraci, Raffaella Marasco, Federica Catalano, Francesco Andreozzi, Marta Letizia Hribal, Francesco Luzza, Giorgio Sesti. Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. Diabetes Research and Clinical Practice 2022; 185 doi: 10.1016/j.diabres.2022.109789
350
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging Perspective. Contrast Media & Molecular Imaging 2018; 2018 doi: 10.1155/2018/9487938
351
Hui Zhao, Xiang Gao, Zhizuo Liu, Lei Zhang, Xuan Fang, Jianping Sun, Zhaofeng Zhang, Yongye Sun. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats. Nutrients 2022; 14(22) doi: 10.3390/nu14224846
352
Maha Saad, Walaa Ibrahim, Amany Helmy Hasanin, Aya Magdy Elyamany, Marwa Matboli. Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway. RSC Medicinal Chemistry 2024; 15(11) doi: 10.1039/D4MD00477A
353
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2) doi: 10.1159/000504602
354
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
355
Rongjia Qi, Rong Jiang, Hanxianzhi Xiao, Ziling Wang, Siyuan He, Lu Wang, Yaping Wang. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor. Life Sciences 2020; 254 doi: 10.1016/j.lfs.2020.117776
356
Erlin Chen, Bin Zhou, Saiyan Bian, Wenkai Ni, Zhong Chen, Gagan Chhabra. The lncRNA B3GALT5-AS1 Functions as an HCC Suppressor by Regulating the miR-934/UFM1 Axis. Journal of Oncology 2021; 2021 doi: 10.1155/2021/1776432
357
Han Zhang, Qinghui Niu, Kun Liang, Xuesen Li, Jing Jiang, Cheng Bian. Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021;  doi: 10.2147/DMSO.S338097
358
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
359
. 2019;  doi: 10.70675/8139d5c7zb3b1z466az837az2b9408b374a8
360
Mandour Omer Mandour, Mohammed El-Hassan, Rawan M Elkomi, Jude A Oben. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?. World Journal of Hepatology 2022; 14(9): 1704-1717 doi: 10.4254/wjh.v14.i9.1704
361
Xian-ju Huang, Cai-jing He, Shuai Liang, Jing Wang, Jun Li, Guang-zhong Yang, Zhang Zhao. Veratrilla baillonii Franch Could Alleviate Lipid Accumulation in LO2 Cells by Regulating Oxidative, Inflammatory, and Lipid Metabolic Signaling Pathways. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.575772
362
Michael J. Trujillo, Johnson Chen, Jonathan M. Rubin, Jing Gao. Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A review. Clinical Imaging 2021; 78 doi: 10.1016/j.clinimag.2021.02.039
363
FUJI YANG, YAN HUANG, YOUWEN TAN, YONGMIN YAN. Ubiquitin-like posttranslational modifications in NAFLD progression and treatment. BIOCELL 2022; 46(2) doi: 10.32604/biocell.2021.015899
364
Alexandra Wuopio, Brett M. Baker, Benjamin Koethe, Martin D. Goodman, Reuben Shin, Nikolay Bugaev, Dmitry Nepomnayshy, Woon Cho Kim, Thomas Schnelldorfer. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery?. Obesity Surgery 2024; 34(3) doi: 10.1007/s11695-024-07070-2
365
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12) doi: 10.1007/s10620-019-05716-1
366
Vlad Pădureanu, Mircea Cătălin Forțofoiu, Mircea Pîrșcoveanu, Rodica Pădureanu, Dumitru Rădulescu, Ionuț Donoiu, Denisa Floriana Vasilica Pîrșcoveanu. Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease. Metabolites 2025; 15(3) doi: 10.3390/metabo15030149
367
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep Tissue. Ultrasound in Medicine & Biology 2021; 47(7) doi: 10.1016/j.ultrasmedbio.2021.03.005
368
Raúl Gómez-Mendoza, Fabiola Sánchez-Hernández, Francisco Javier Valentin-Cortez, Norberto Chávez-Tapia. Fatty liver disease in the pediatric population: history, definitions, and challenges in nomenclature (NAFLD/MAFLD/MASLD). Metabolism and Target Organ Damage 2025; 5(2) doi: 10.20517/mtod.2024.108
369
Yujin Park, Deepthi Thadasina, Ifeoluwa Bolujo, Abdulkadir Isidan, Arthur A. Cross-Najafi, Kevin Lopez, Ping Li, Andrew M. Dahlem, Lindsey Kennedy, Keisaku Sato, Heather Francis, Gianfranco Alpini, Wenjun Zhang, Burcin Ekser. Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2022; 42(04) doi: 10.1055/a-1934-5588
370
Dong Li, Meina Shi, Zhike Fang, Xiaoqing Wang, Linshi Huang, Mingguo Dong, Andrey Elchaninov. Ophiopogonin D Alleviates Nonalcoholic Steatohepatitis via Ferroptosis Through AKT1/STAT3/HIF‐1α Axis. Analytical Cellular Pathology 2026; 2026(1) doi: 10.1155/ancp/5567109
371
Hongkun Xue, Yu Wang, Hongwei Xiang, Qi Song, Guowei Zhang, Jianguo Wang, Shaoqin Ge, Rajeev K Singla. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/5440347
372
Yue Zhou, Yunzhi Ni, Zhihong Wang, Gerald J. Prud’homme, Qinghua Wang. Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1283739
373
Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland. Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(1) doi: 10.3390/biomedicines10010195
374
Jitka Starekova, David Rutkowski, Won C. Bae, Hung Do, Ananth J. Madhuranthakam, Vadim Malis, Sheng Qing Lin, Suraj Serai, Takeshi Yokoo, Scott B. Reeder, Jean H. Brittain, Diego Hernando. Multi‐Center, Multi‐Vendor Validation of Simultaneous MRI‐Based Proton Density Fat Fraction and R2* Mapping Using a Combined Proton Density Fat Fraction‐R2* Phantom. Journal of Magnetic Resonance Imaging 2025; 62(3) doi: 10.1002/jmri.29775
375
Xu Zhang, Xianzhao Yang, Lanshuo Hu, Lingjie Tan, Xiaoyang Li, Yijie Chai, Shuying Ru. Association between air pollution and risk of non-alcoholic fatty liver disease: an updated meta-analysis. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1606959
376
Felipe David Mendonça Chaim, Lívia Bitencourt Pascoal, Fábio Henrique Mendonça Chaim, Bruna Biazon Palma, Tiago Andrade Damázio, Larissa Bastos Eloy da Costa, Rita Carvalho, Everton Cazzo, Martinho Antônio Gestic, Murillo Pimentel Utrini, Marciane Milanski, Elinton Adami Chaim, Raquel Franco Leal. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65556-2
377
Lijuan Li, Kun Hou, Mengya Yuan, Yan Zhang, Yang Zhang. Change lifestyle modification plan/transtheoretical model in non-alcoholic simple fatty liver disease: a pilot randomized study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02506-4
378
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020; 12(4) doi: 10.3390/nu12040933
379
Yuhong Tang, Yujuan Fan, Yiming Wang, Dong Wang, Qingyu Huang, Tongqing Chen, Xinyue Cao, Cailing Wen, Xiaoyan Shen, Jian Li, Yan You. A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development. Biomedicine & Pharmacotherapy 2024; 175 doi: 10.1016/j.biopha.2024.116658
380
Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Beomkyung Kim. A qualitative study of self‐management experiences in people with non‐alcoholic fatty liver disease. Nursing Open 2021; 8(6) doi: 10.1002/nop2.1025
381
Sercan Kaya, Murat Boydak, Mesut Aydin, İbrahim Aras. Association between serum cytokeratin 18 and N-terminal procollagen III propeptide in patients with biopsy-proven nonalcoholic fatty liver disease*. Biotechnic & Histochemistry 2024; 99(6) doi: 10.1080/10520295.2024.2385011
382
Kohei Ariyoshi, Kazuhiro Nishiyama, Yuri Kato, Xinya Mi, Tomoya Ito, Yasu-Taka Azuma, Akiyuki Nishimura, Motohiro Nishida. Inhibition of Drp1–Filamin Protein Complex Prevents Hepatic Lipid Droplet Accumulation by Increasing Mitochondria–Lipid Droplet Contact. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105446
383
Hangkai Huang, Zhening Liu, Jiaqi Ruan, Zejun Fang, Chengfu Xu. Laparoscopically confirmed endometriosis and the risk of incident NAFLD: a prospective cohort study. Reproductive Biology and Endocrinology 2025; 23(1) doi: 10.1186/s12958-025-01391-2
384
Hendrik Strebel, Bernhard Haller, Maximilian Sohn, Wolfgang Schepp, Felix Gundling. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE - Portuguese Journal of Gastroenterology 2020; 27(6) doi: 10.1159/000507225
385
Vahid Sheikhi, Zahra Heidari. Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Shiraz E-Medical Journal 2021; 23(3) doi: 10.5812/semj.118125
386
Sandra Calixto-Tlacomulco, Ismael Luna-Reyes, Blanca Delgado-Coello, Roxana Gutiérrez-Vidal, Juan Pablo Reyes-Grajeda, Jaime Mas-Oliva. CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells. Archives of Medical Research 2024; 55(2) doi: 10.1016/j.arcmed.2023.102937
387
Emilie S. Zoltick, Stephanie A. Smith-Warner, Chen Yuan, Molin Wang, Charles S. Fuchs, Jeffrey A. Meyerhardt, Andrew T. Chan, Kimmie Ng, Shuji Ogino, Meir J. Stampfer, Edward L. Giovannucci, Kana Wu. Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival. British Journal of Cancer 2021; 125(7) doi: 10.1038/s41416-021-01487-7
388
Eric M Sieloff, Brian Rutledge, Cuyler Huffman, Duncan Vos, Thomas Melgar. National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database. Gastroenterology Report 2021; 9(1) doi: 10.1093/gastro/goaa091
389
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms 2020; 8(10) doi: 10.3390/microorganisms8101526
390
Yunjung Choi, Chang Hun Lee, In Hee Kim, Eun Hae Park, SoJeong Park, Wan-Hee Yoo. Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study. Clinical Rheumatology 2021; 40(5) doi: 10.1007/s10067-020-05456-y
391
Shuaibing He, Hantao Chen, Yanfeng Yi, Diandong Hou, Xuyan Fu, Jinlu Xie, Juan Zhang, Chongbin Liu, Xiaochen Ru, Juan Wang. A novel bioinformatics strategy to uncover the active ingredients and molecular mechanisms of Bai Shao in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1406188
392
Qin Liu, Chun-Yan Niu. From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease. World Chinese Journal of Digestology 2019; 27(19) doi: 10.11569/wcjd.v27.i19.1171
393
Cheng Zhou, Wenji Zhang, Hui Lin, Luyun Zhang, Fan Wu, Yan Wang, Susu Yu, Xinyue Peng, Wenli Cheng, Min Li, Xiaoying Pan, Zhenrui Huang, Wenjuan Zhang. Effect of theaflavin-3,3′-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.925264
394
Seung Mi Yeo, Joo Hyun Oh, Hee Ju Yu, Dong Hyun Sinn, Ji Hye Hwang. The effect of mHealth-based exercise on Insulin Sensitivity for patients with Hepatocellular carcinoma and insulin resistance (mISH): protocol of a randomized controlled trial. Trials 2022; 23(1) doi: 10.1186/s13063-022-06858-w
395
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. AACE Clinical Case Reports 2022; 8(1) doi: 10.1016/j.aace.2021.07.001
396
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Juan D. Rodriguez-Callejas, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Karla Gil-Becerril, Verónica Rocío Vásquez-Garzón, Jaime Arellanes-Robledo, Víctor Tsutsumi, Saúl Villa-Treviño, Pablo Muriel. Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH. Annals of Hepatology 2023; 28(1) doi: 10.1016/j.aohep.2022.100780
397
Mina Karimi, Behnaz Abiri, Paul C. Guest, Mohammadreza Vafa. Physical Exercise and Natural and Synthetic Products in Health and Disease. Methods in Molecular Biology 2022; 2343 doi: 10.1007/978-1-0716-1558-4_2
398
Yuhan Zhang, Lusi Xu, Yiran Lu, Jing Zhang, Mengge Yang, Yutian Tian, Jianjun Dong, Lin Liao. Protective effect of Cordyceps sinensis against diabetic kidney disease through promoting proliferation and inhibiting apoptosis of renal proximal tubular cells. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03901-4
399
. 2021;  doi: 10.70675/00f56ed9z2249z4285zbb57z3aa47bb72094
400
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?. Ultrasonography 2023; 42(2) doi: 10.14366/usg.22122
401
Anupamjeet Kaur Sekhon, Aniruddha Gollapalli, Dharamjeet Kaur, Bryan Janssen, Mark L. Stevens, Fernando Valerio, Miguel A. Sierra-Hoffman. A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH). American Journal of Case Reports 2021; 22 doi: 10.12659/AJCR.932961
402
Alanoud Maan Alyousef, Doaa Zeinhom Mekawy, Yaser Yousef Bashumeel, Saleh Magdy Mohamed, Turky H. Almigbal, Mohammed A. Batais, Abdullah A. Alrasheed. The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease in primary care clinics at King Saud University Medical City, Riyadh, Saudi Arabia. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1551201
403
Kiarash Riazi, Hassan Azhari, Jacob H. Charette, Fox E. Underwood, James A. King, Elnaz Ehteshami Afshar, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel Aziz Shaheen. . 2022;  doi: 10.2139/ssrn.4002396
404
Mariana F. Leite, Ariele B. Haagsma, Paulo-André B. Machado-Júnior, Grasiele L. Martins, Márcia Olandoski, Cristina P. Baena. Association between serum uric acid levels and incidence of nonalcoholic fatty liver disease in users of preventive medicine service in southern Brazil: a retrospective study. Bulletin of the National Research Centre 2022; 46(1) doi: 10.1186/s42269-022-00848-3
405
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease. Journal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
406
Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy. Physiology International 2021; 108(4) doi: 10.1556/2060.2021.00188
407
Zhe Jiang, Takuya Hayashi, Kentaro Kashima, Kayo Kurotani, Bungo Shirouchi, Tetsuya Mizoue, Masao Sato. Alteration of Serum Phospholipid n‐6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross‐Sectional Study. Lipids 2020; 55(6) doi: 10.1002/lipd.12251
408
Raznin Joly, Fariha Tasnim, Kelsey Krutsinger, Zhuorui Li, Nicholas Pullen, Yuyan Han. Cannabigerol Alleviates Liver Damage in Metabolic Dysfunction-Associated Steatohepatitis Female Mice via Inhibition of Transforming Growth Factor Beta 1. Nutrients 2025; 17(9) doi: 10.3390/nu17091524
409
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Tomoko Asai, Ai Tsuji, Satoru Matsuda. Metabolic Associated Fatty Liver Disease as a Risk Factor for the Development of Central Nervous System Disorders. Livers 2023; 3(1) doi: 10.3390/livers3010002
410
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
411
David M. Rodrigues, Arjun Kundra, Lawrence Hookey, Steven Montague. Does Point-of-Care Ultrasound Change the Needle Insertion Location During Routine Bedside Paracentesis?. Journal of General Internal Medicine 2022; 37(7) doi: 10.1007/s11606-021-07042-7
412
Robert N. Helsley, Se-Hyung Park, Hemendra J. Vekaria, Patrick G. Sullivan, Lindsey R. Conroy, Ramon C. Sun, María del Mar Romero, Laura Herrero, Joanna Bons, Christina D. King, Jacob Rose, Jesse G. Meyer, Birgit Schilling, C. Ronald Kahn, Samir Softic. Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation. Journal of Hepatology 2023; 79(1) doi: 10.1016/j.jhep.2023.02.010
413
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver Disease. Alternative and Complementary Therapies 2020; 26(6) doi: 10.1089/act.2020.29303.klu
414
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1) doi: 10.1016/j.iliver.2022.02.004
415
Lu Fan, Hongjuan Niu, Linyi Zhao, Rongfei Yao, Xu He, Binan Lu, Zongran Pang. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. Biomedicine & Pharmacotherapy 2022; 148 doi: 10.1016/j.biopha.2022.112697
416
Tsung-Hsuan Wu, Hung-Chih Chiu, Jyun-Sin Wu, Wei-Jong Yang, Kuo-Sheng Cheng, Che-Wei Hsu, Shu-Hsien Wang, Joshua Tay Uyboco, Hung-Wen Tsai, Pau-Choo Chung. BSMatch: Boundary Segmentation and Matching for Lipid Droplet Quantification in Diagnosis of Non-Alcoholic Fatty Liver Disease. IEEE Journal of Biomedical and Health Informatics 2025; 29(8) doi: 10.1109/JBHI.2025.3556709
417
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin. Gastroenterology Insights 2021; 12(2) doi: 10.3390/gastroent12020014
418
Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
419
Najla A. Lakkis, Nour M. Mokalled, Mona H. Osman, Umayya M. Musharrafieh, Mohammad Eljammal. Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data. Cancer Control 2024; 31 doi: 10.1177/10732748241297346
420
Sisi Yan, Sha Liu, Jianyu Qu, Xiaowen Li, Jiahao Hu, Linyu Zhang, Xiangyan Liu, Xin Li, Xianglin Wang, Lixin Wen, Ji Wang. A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Nutrients 2022; 14(3) doi: 10.3390/nu14030560
421
Raj Shah, Sagarika Satyavada, Perica Davitkov. Nutrition, Weight, and Digestive Health. 2022;  doi: 10.1007/978-3-030-94953-2_7
422
Olfa Khalifa, Khalid Ouararhni, Khaoula Errafii, Nehad M. Alajez, Abdelilah Arredouani. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411606
423
Catarina Baptista, Francisco Esteves, Jonathan A. Fallowfield, Timothy J. Kendall, Leonard J. Nelson, Michel Kranendonk. Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 2026; 23(8) doi: 10.1038/s41575-026-01202-y
424
Alexander Kusnik, Nicole Hunter, Erik Rasbach, Thomas Miethke, Christoph Reissfelder, Matthias Philip Ebert, Andreas Teufel. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular Carcinoma. Digestive Diseases 2021; 39(5) doi: 10.1159/000514277
425
Qiyi Yu, Yidong Zhang, Jiaping Ni, Yumeng Shen, Weiwei Hu. Identification and analysis of significant genes in nonalcoholic steatohepatitis-hepatocellular carcinoma transformation: Bioinformatics analysis and machine learning approach. Molecular Immunology 2024; 174 doi: 10.1016/j.molimm.2024.07.015
426
Wiebke Breternitz, Friedrich Sandkühler, Frauke Grohmann, Jochen Hampe, Mario Brosch, Alexander Herrmann, Clemens Schafmayer, Christian Meinhardt, Stefan Schreiber, Alexander Arlt, Claudia Geismann. The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression. Cells 2022; 11(21) doi: 10.3390/cells11213504
427
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12) doi: 10.1055/a-1212-6017
428
Jie-Ying Zhu, Liang Guo. Exercise-regulated lipolysis: Its role and mechanism in health and diseases. Journal of Advanced Research 2025; 75 doi: 10.1016/j.jare.2024.11.031
429
Yusuf Yilmaz, Christopher D. Byrne, Giovanni Musso. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology 2021; 15(4) doi: 10.1080/17474124.2021.1860019
430
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population. Hepatology Research 2022; 52(8) doi: 10.1111/hepr.13790
431
Mak-Soon Lee, Cheamin Kim, Hyunmi Ko, Yangha Kim. Inhibitory effect of water-soluble mulberry leaf extract on hepatic lipid accumulation in high-fat diet-fed rats via modulation of hepatic microRNA-221/222 expression and inflammation. Journal of Nutrition and Health 2022; 55(2) doi: 10.4163/jnh.2022.55.2.227
432
Aldo J. Montaño-Loza. Evaluación de la fibrosis en pacientes con enfermedad de hígado graso no alcohólico. Revista de Gastroenterología de México 2022; 87(1) doi: 10.1016/j.rgmx.2021.04.004
433
Karl Nadolsky, Donna R. Cryer, Amy Articolo, Travis Fisher, Jennifer Schneider, Mary Rinella. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2211349
434
Doina Georgescu, Ana Lascu, Ioana Ionita, Oana-Elena Ancusa, Mihai Ionita, Ciprian Rosca, Despina Calamar-Popovici, Daniel Lighezan. Advances in Probiotics for Health and Nutrition. 2024;  doi: 10.5772/intechopen.110134
435
Zizuo Zhao, Tiankuo Luan, Jingyuan Wan, Hui Du, Jun Hu, Hao Liu, Xia Gong, Ge Kuang, Bin Wang. Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. Medicina 2023; 59(9) doi: 10.3390/medicina59091639
436
Hejun Li, Ying Zhang, Hengcong Luo, Rong Lin. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.977625
437
. 2023;  doi: 10.70675/ecaf4c85z1295z4280zb43ezdb58695f5ff8
438
Arun J. Sanyal, Jérémy Magnanensi, Zouher Majd, Christian Rosenquist, Delphis M. Vera, James P. Almas, Margery A. Connelly. NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older. Hepatology Communications 2023; 7(9) doi: 10.1097/HC9.0000000000000223
439
Teresa Vanessa Fiorentino, Elena Succurro, Angela Sciacqua, Francesco Andreozzi, Francesco Perticone, Giorgio Sesti. Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. Diabetes/Metabolism Research and Reviews 2020; 36(8) doi: 10.1002/dmrr.3333
440
Thomas A Beltran, Sean M Rogers, Jessica N Molina, Carlos J Maldonado, Cristóbal S Berry-Cabán, Young S Choi. Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort. Military Medicine 2026; 191(Supplement_1) doi: 10.1093/milmed/usag117
441
Jiayun M. Fang, Jerome Cheng, Michael F. Chang, Joseph Ahn, Maria Westerhoff. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint. Modern Pathology 2021; 34(10) doi: 10.1038/s41379-021-00851-5
442
Vania Morales, Andrea González, Claudio Cabello-Verrugio. Advances in Molecular Pathology. Advances in Experimental Medicine and Biology 2023; 1408 doi: 10.1007/978-3-031-26163-3_11
443
Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. Journal of Clinical Gastroenterology 2021; 55(10) doi: 10.1097/MCG.0000000000001409
444
M. Zhao, Y. Hu, C. Shi, K. Wang, J. Li, J. Song, C. Huo, Y. Xi, S. Bu, Q. Huang. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population. Public Health 2022; 202 doi: 10.1016/j.puhe.2021.10.012
445
Veera Houttu, Julia Bouts, Yasaman Vali, Joost Daams, Aldo Grefhorst, Max Nieuwdorp, Adriaan G. Holleboom. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032164
446
Nikta Afzali, Seyed Shayan Ebadi, Hasan Afzali, Mohammad Reza Sharif, Mahdi Vazirian, Seyed Alireza Ebadi, Vahid Shahkarami, Habibollah Rahimi. Effect of Beta vulgaris Extract on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Hepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.102125
447
Changhui Yu, Shiming He, Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study. BMC Endocrine Disorders 2024; 24(1) doi: 10.1186/s12902-024-01554-z
448
Doudou Li, Yacong Bo, Yao Chen, Zhitian Guo, Li Li, Wenjie Zhang, Mingyi Xue, Yongjian Zhu, Liuhang Ren, Tingting Li, Zhan Gao. Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1845611
449
Hannah R. McDowell, Cher Shiong Chuah, Dhiraj Tripathi, Adrian J. Stanley, Ewan H. Forrest, Peter C. Hayes. Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study. Alimentary Pharmacology & Therapeutics 2021; 53(4) doi: 10.1111/apt.16189
450
Zi Zeng, Hua Wei, Yuejuan Dong, Sijin Sun, Zhuoma Sunu. What diet is optimal in adults with metabolic dysfunction-associated steatotic liver disease? A systematic review and network meta-analysis. Nutrition Clinique et Métabolisme 2025; 39(4) doi: 10.1016/j.nupar.2025.08.004
451
Yuqin Zhang, Liping Hua, Chunfeng Lin, Mingzhou Yuan, Wei Xu, Anand Raj D., Baskar Venkidasamy, Carlos L. Cespedes-Acuna, Shivraj Hariram Nile, Guohong Yan, Haiyin Zheng. Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.937484
452
Teresa Y. Oh, Sirish Palle, A. Jay Freeman. Update in Pediatrics. 2023;  doi: 10.1007/978-3-031-41542-5_16
453
Oana Albai, Adina Braha, Romulus Timar, Sandra Lazăr, Simona Popescu, Bogdan Timar. The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease. Medicina 2025; 61(10) doi: 10.3390/medicina61101850
454
Ping Chen, Yusheng Li, Li Xiao. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10543
455
O. M. Drapkina, S. V. Nedogoda. Metabolic dysfunction-associated steatotic liver disease in metabolic syndrome. Russian Journal of Cardiology 2025; 30(1S) doi: 10.15829/1560-4071-2025-6541
456
Mingjie Xu, Yushuang Wei, Lingyu Ye, Boteng Yan, Shengzhu Huang, Zengnan Mo, Mingli Li. Novel obesity and metabolic indices better predict non-alcoholic fatty liver disease in elderly T2DM patients: evidence from cross-sectional and longitudinal analysis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1649466
457
Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022; 3 doi: 10.1016/j.obpill.2022.100027
458
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019;  doi: 10.1007/978-3-030-21540-8_13
459
Lyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz. Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed mice. Annals of Hepatology 2020; 19(5) doi: 10.1016/j.aohep.2020.06.005
460
Kabelo Mokgalaboni, Yonela Ntamo, Khanyisani Ziqubu, Tawanda M. Nyambuya, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, Kwazikwakhe B. Gabuza, Nireshni Chellan, Luca Tiano, Phiwayinkosi V. Dludla. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. Food & Function 2021; 12(24) doi: 10.1039/D1FO02696H
461
Г. Д. Фадєєнко, О. Є. Гріднєв, І. Е. Кушнір, Т. А. Соломенцева, В. М. Чернова, В. Ю. Гальчінська. Роль кишкової мікробіоти, ендотоксемії та системного запалення у патогенезі неалкогольної жирової хвороби печінки. Lviv clinical bulletin 2022; (3-4(39-40)) doi: 10.25040/lkv2022.03-04.008
462
Davide Guido, Nicole Cerabino, Martina Di Chito, Vincenza Di Stasi, Sara De Nucci, Endrit Shahini, Vito Giannuzzi, Raffaele Cozzolongo, Sergio Coletta, Dolores Stabile, Anna Ancona, Giovanna Longo, Luigi Fontana, Gianluigi Giannelli, Giovanni De Pergola. Association between liver steatosis, fibrosis, and the onset of type 2 diabetes in overweight individuals: A fibroscan-based study in Southern Italy. Diabetes Research and Clinical Practice 2024; 218 doi: 10.1016/j.diabres.2024.111911
463
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Intestinal Absorption of Bile Acids in Health and Disease. Comprehensive Physiology 2020; 10(1) doi: 10.1002/j.2040-4603.2020.tb00108.x
464
Jintong Pan, Wei Ye, Jinmeng Zhang, Ye Fan, Zaohong Chen, Yuxue Wang, Xiang Liu. Knockdown of Salusin‐β Downregulates FTO to Inhibit Lipid Synthesis and Promote Lipolysis to Attenuate NAFLD. Liver International 2025; 45(9) doi: 10.1111/liv.70252
465
Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Sneha Teresa Selvin, Sonu Thomas, Pousette Hamid. Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know . Cureus 2022;  doi: 10.7759/cureus.28052
466
Mohamed Abdel-Samiee, Essam Salah Ibrahim, Mohamed Kohla, Eman Abdelsameea, Mohsen Salama. Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(6): 97381 doi: 10.4292/wjgpt.v15.i6.97381
467
O.E. Abaturov, A.O. Nikulina. Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions. CHILD`S HEALTH 2024; 19(2) doi: 10.22141/2224-0551.19.2.2024.1683
468
Hee Jin Jeong, Song Hee Lee, Hee Eun Kang. Changes in digoxin pharmacokinetics associated with hepatic P‐glycoprotein upregulation in rats with non‐alcoholic fatty liver disease. Fundamental & Clinical Pharmacology 2021; 35(6) doi: 10.1111/fcp.12687
469
Jacob J. Swidorski, Brett R. Beno, Chunjian Liu, David S. Yoon, Kaushik Ghosh, Harinath Sale, Devang Shah, Kriti Acharya, Joseph Yanchunas, Priyanka Haldar, Narasimharaju Kalidindi, Jinal K. Shukla, Matthew Argentieri, Bruce A. Ellsworth, Dong Cheng, Alicia Regueiro-Ren. Discovery and exploration of monosaccharide linked dimers of galectin-3 inhibitors to target fibrosis. Medicinal Chemistry Research 2023; 32(7) doi: 10.1007/s00044-023-03087-x
470
Qian Wang, Huiyi Chen, Huiling Deng, Minyi Zhang, Haoyue Hu, Haotong Ouyang, Lien Ma, Ruiyan Liu, Jian Sun, Guifang Hu, Kaifeng Wang. Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes. Diabetes & Metabolism 2025; 51(3) doi: 10.1016/j.diabet.2025.101628
471
Emine Turkkan, Huseyin Dag, Okan Dikker, Nevin Cetin Dag, Alper Kacar, Soner Sazak. Omentin-1 Levels and Non-alcoholic Fatty Liver Disease in Obese Adolescents. Iranian Journal of Pediatrics 2021; 31(5) doi: 10.5812/ijp.117353
472
Nicholas A. Cumpian, Julio A. Gutierrez, William Wu, Sammy Saab. Targeting MASLD and MASH in the US Hispanic/Latino Population. JAMA Internal Medicine 2025; 185(11) doi: 10.1001/jamainternmed.2025.4769
473
Soumya Murag, Aijaz Ahmed, Donghee Kim. Recent Epidemiology of Nonalcoholic Fatty Liver Disease. Gut and Liver 2021; 15(2) doi: 10.5009/gnl20127
474
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial. Nutrition Research 2020; 73 doi: 10.1016/j.nutres.2019.08.009
475
Aldo J. Montaño-Loza. Evaluation of fibrosis in patients with nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2022; 87(1) doi: 10.1016/j.rgmxen.2021.10.004
476
Shan Dang, Jian Zhou, Zongyan Wang, Kunning Wang, Shejiao Dai, Shuixiang He. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 106 doi: 10.1016/j.biopha.2018.06.042
477
Minhee Lee, Dakyung Kim, So Jung Park, Kyung Seok Kim, Geum Duck Park, Ok-Kyung Kim, Jeongmin Lee. Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease. Journal of Medicinal Food 2021; 24(10) doi: 10.1089/jmf.2021.K.0069
478
Aref Yarahmadi, Hamed Afkhami. The role of microbiomes in gastrointestinal cancers: new insights. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1344328
479
Lin Wei, Hui-Guo Ding. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease. Medicine 2021; 100(31) doi: 10.1097/MD.0000000000026706
480
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11) doi: 10.1016/j.medcli.2021.12.003
481
Srijyotsna Volety, James Rice, Wonhyeok Lee, Caroline Doctor, Jack Gwertzman, Greta Boehm, Melih Eriten, Ali Pirasteh, Alejandro Roldán-Alzate, Diego Hernando. Quantitative evaluation of shear stiffness and the apparent diffusion coefficient using anthropomorphic multi-stiffness liver phantoms under static and motion conditions. Magnetic Resonance Imaging 2027; 135 doi: 10.1016/j.mri.2026.110782
482
Sydney Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Ethan Miller, Julia Wattacheril. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications 2020; 4(11) doi: 10.1002/hep4.1575
483
Allyce Caines, Ranya Selim, Reena Salgia. The Changing Global Epidemiology of Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4) doi: 10.1016/j.cld.2020.06.001
484
María Juárez-Fernández, David Porras, María García-Mediavilla, Sara Román-Sagüillo, Javier González-Gallego, Esther Nistal, Sonia Sánchez-Campos. Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions. Nutrients 2020; 13(1) doi: 10.3390/nu13010016
485
Ahmed M. F. Mansour, Ehab Nashaat, Asmaa Gouda Seliem Hassan Mohamed, Ahmed Mohamed ElGhandour. Serum Mac-2 binding protein glycosylation isomer as a biomarker for metabolic dysfunction associated steatotic liver disease. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00419-x
486
J. Bronsard, C. Savary, J. Massart, R. Viel, L. Moutaux, D. Catheline, V. Rioux, B. Clement, A. Corlu, B. Fromenty, P.J. Ferron. 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments. Toxicology in Vitro 2024; 94 doi: 10.1016/j.tiv.2023.105728
487
Verena C Obmann, Christina Marx, Annalisa Berzigotti, Nando Mertineit, Joris Hrycyk, Christoph Gräni, Lukas Ebner, Michael Ith, Johannes T Heverhagen, Andreas Christe, Adrian T Huber. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis. European Journal of Radiology 2019; 118 doi: 10.1016/j.ejrad.2019.07.001
488
Quinten J. J. Augustijn, Aldo Grefhorst, Pleun de Groen, Koen Wortelboer, Jos F ML Seegers, Ismail Sahin Gül, Peter Suenaert, Joanne Verheij, Willem M. de Vos, Hilde Herrema, Max Nieuwdorp, Adriaan G. Holleboom. Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis. BMJ Open 2025; 15(1) doi: 10.1136/bmjopen-2024-088290
489
Rebecca K. Vincent, David M. Williams, Marc Evans. A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?. Diabetes, Obesity and Metabolism 2020; 22(12) doi: 10.1111/dom.14196
490
Jiahui Li, Hao Wu, Kevin J. Glaser, Fang-Shu Ou, Armando Manduca, Sudhakar K. Venkatesh, Claude Sirlin, Rohit Loomba, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography. Hepatology Communications 2026; 10(9) doi: 10.1097/HC9.0000000000001024
491
Isha Patel, Arti Yadav, Suchit Swaroop. Association of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic Syndrome in Adult Population: A Narrative Review. Journal of Ecophysiology and Occupational Health 2024;  doi: 10.18311/jeoh/2024/36032
492
Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel K. Elmquist, Philipp E. Scherer, Jay D. Horton. Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD. Journal of Clinical Investigation 2021; 131(22) doi: 10.1172/JCI152242
493
ABDALBASET ALDEEP, FATMA SOOF, SEHAM ALBADRI, MARWA MIFTAH AMHARIB, HASSAN SULIMAN MUFTAH. PREVALENCE OF NAFLD IN THE GULF OF SIDRA, LIBYA. NOON Scientific Journal 2026;  doi: 10.64587/NOONSJ.v26i.2429
494
Sangwon F. Kim, Jang Hyun Choi. Metabolic Syndrome. 2023;  doi: 10.1007/978-3-031-40116-9_36
495
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(7) doi: 10.3390/jcm9072032
496
Guangpin Zeng, Guanghong Li, Xinghong Lin, Shoude Yang, Linran Zeng. Cross-sectional analysis of adult fatty liver prevalence in Wenshan, China: an epidemiologic study using ultrasound and laboratory assessments. Frontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1571261
497
Ioannis Ilias, Spyridon Goulas, Lina Zabuliene. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World Journal of Clinical Cases 2021; 9(12): 2711-2720 doi: 10.12998/wjcc.v9.i12.2711
498
Yuan Liu, Jinxin Zheng, Jialing Hao, Rang Rang Wang, Xueni Liu, Peng Gu, Hongwei Yu, Yang Yu, Chuanxing Wu, Baochi Ou, Zhihai Peng. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Medicine 2022; 11(5) doi: 10.1002/cam4.4551
499
Yan-yun Shu, Wen-kang Gao, Hui-kuan Chu, Ling Yang, Xiao-li Pan, Jin Ye, Lianxiang Luo. Attenuation by Time‐Restricted Feeding of High‐Fat and High‐Fructose Diet‐Induced NASH in Mice Is Related to Per2 and Ferroptosis. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/8063897
500
Ewa Rudnicka, Anna Maria Duszewska, Marek Kucharski, Paweł Tyczyński, Roman Smolarczyk. OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome. Reproduction 2022; 164(6) doi: 10.1530/REP-22-0152
501
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1) doi: 10.52547/ismj.25.1.30
502
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
503
Marc Evans, Angharad R. Morgan, Dipesh Patel, Ketan Dhatariya, Sharlene Greenwood, Philip Newland-Jones, Debbie Hicks, Zaheer Yousef, Jim Moore, Bethany Kelly, Sarah Davies, Umesh Dashora. Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications. Diabetes Therapy 2021; 12(1) doi: 10.1007/s13300-020-00963-2
504
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseases. Phytotherapy Research 2020; 34(6) doi: 10.1002/ptr.6598
505
Weiwei Zhu, Namood E Sahar, Hafiz Muhammad Ahmad Javaid, Eun Seon Pak, Guang Liang, Yi Wang, Hunjoo Ha, Joo Young Huh. Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2. Cells 2021; 10(12) doi: 10.3390/cells10123306
506
Antoni Sureda, Xavier Capó, Silvia Tejada. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021;  doi: 10.1016/B978-0-12-816488-4.00007-3
507
Andrew M. Moon, Stephanie E. Watkins, Anna S. Lok, Roberto J. Firpi-Morell, Huy Ngoc Trinh, Justin T. Kupec, Cheryl Schoen, Brent A. Neuschwander-Tetri, A. Sidney Barritt. Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. Digestive Diseases 2021; 39(3) doi: 10.1159/000511074
508
Aman Sharma. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Future Journal of Pharmaceutical Sciences 2022; 8(1) doi: 10.1186/s43094-021-00395-0
509
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7) doi: 10.3390/curroncol29070356
510
Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira. Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study. Obesity Science & Practice 2024; 10(2) doi: 10.1002/osp4.751
511
Elham Karimi-Sales, Sajad Jeddi, Mohammad Reza Alipour. trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed rats. Archives of Physiology and Biochemistry 2022; 128(5) doi: 10.1080/13813455.2020.1764045
512
Cayden Beyer, Anneli Andersson, Elizabeth Shumbayawonda, Naim Alkhouri, Ami Banerjee, Prashant Pandya, Mukesh Harisinghani, Kathleen Corey, Andrea Dennis, Michele Pansini. Quantitative MRI for Monitoring Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Test–Retest Repeatability Study. Journal of Magnetic Resonance Imaging 2025; 61(4) doi: 10.1002/jmri.29610
513
Masaya Okada, Masakazu Hanayama, Yasunori Yamamoto, Teruki Miyake, Osamu Yoshida, Eiji Takeshita, Yoshio Ikeda, Yoichi Hiasa. Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03967-z
514
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
515
Maryam Nilghaz, Amir Sadeghi, Glareh Koochakpoor, Hossein Poustchi, Navideh Khodadadi, Behnaz Narimani, Maryam Ghods, Mahshad Shafiee, Mohammad Reza Shahparvari, Azita Hekmatdoost. The efficacy of DASH combined with time-restricted feeding (16/8) on metabolic associated fatty liver disease management: a randomized controlled trial. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-88393-7
516
Xuan G. Luong, Sarah K. Stevens, Andreas Jekle, Tse-I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M. Blatt, Leonid N. Beigelman, Julian A. Symons, Pierre Raboisson, David McGowan, Koen Vandyck, Jerome Deval, Olivier Barbier. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). PLOS ONE 2020; 15(12) doi: 10.1371/journal.pone.0240338
517
Cayden Beyer, Chloe Hutton, Anneli Andersson, Kento Imajo, Atsushi Nakajima, Dustin Kiker, Rajarshi Banerjee, Andrea Dennis, Wan-Long Chuang. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLOS ONE 2021; 16(4) doi: 10.1371/journal.pone.0249491
518
Associated Liver Disease in Alcoholic Chronic Pancreatitis. Academia Journal of Surgery 2020; 3(1) doi: 10.47008/ajs/2020.3.1.37
519
Vasile-Andrei Olteanu, Gheorghe G. Balan, Oana Timofte, Cristina Gena Dascalu, Elena Gologan, Georgiana-Emanuela Gilca-Blanariu, Madalina-Maria Diac, Ion Sandu, Gabriela Stefanescu. Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease. Diagnostics 2022; 12(9) doi: 10.3390/diagnostics12092136
520
Yesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda. Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis. Annals of Hepatology 2022; 27(6) doi: 10.1016/j.aohep.2022.100706
521
Joseph M. Salamoun, Christopher J. Garcia, Stefan R. Hargett, Jacob H. Murray, Sing-Young Chen, Martina Beretta, Stephanie J. Alexopoulos, Divya P. Shah, Ellen M. Olzomer, Simon P. Tucker, Kyle L. Hoehn, Webster L. Santos. 6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry 2020; 63(11) doi: 10.1021/acs.jmedchem.0c00542
522
Yu Chung Chooi, Qinze Arthur Zhang, Faidon Magkos, Maisie Ng, Navin Michael, Xiaorong Wu, Vera Sergeyevna Brok Volchanskaya, Xianning Lai, Elvy Riani Wanjaya, Untzizu Elejalde, Chew Chan Goh, Clara Poh Lian Yap, Long Hui Wong, Kevin Junliang Lim, S. Sendhil Velan, Jadegoud Yaligar, Mark Dhinesh Muthiah, Yap Seng Chong, Evelyn Xiu Ling Loo, Johan G. Eriksson, Kezlyn Li Ming Lim, Mabel Shu Fung Kouk, Evelyn Wai Mei Chong, Munirah Abd Gani, Lisha Li, Vicky Hwee Kee Tay, Yeshe Manuel Kway, Mukkesh Kumar, Suresh Anand Sadananthan, Kaijie Khoo, Danyu Koh, Rebecca Lim, Chin Wei Kang, Kwang Li Sin, Jun Wei Lim. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. The American Journal of Clinical Nutrition 2024; 119(3) doi: 10.1016/j.ajcnut.2023.11.013
523
P. V. Koroy, Yu. A. Kravchenko, A. V. Yagoda. The possibilities of soluble selectins in the prediction of severe fi brosis in nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2022; (3) doi: 10.31146/1682-8658-ecg-199-3-50-56
524
Aysun Yakut. The relationship between serum uric acid levels and liver stiffness in patients with type II diabetes mellitus and fatty liver disease. Revista da Associação Médica Brasileira 2024; 70(12) doi: 10.1590/1806-9282.20241013
525
Azam Teimouri, Zahra Ebrahimpour, Awat Feizi, Bijan Iraj, Elahe Saffari, Mojtaba Akbari, Mozhgan Karimifar. Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1416407
526
Guifen Zhao, Ran'geng Shi, Mao Ma, Hairong Lin, Jianqin Zhang, Binwu Sheng. Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6) doi: 10.1016/j.clinre.2024.102363
527
Eréndira Villanueva-Ortega, Lucia A. Méndez-García, Guadalupe N. Garibay-Nieto, Estibalitz Laresgoiti-Servitje, Patricia Medina-Bravo, Alfonso Olivos-García, Martín H. Muñoz-Ortega, Javier Ventura-Juárez, Galileo Escobedo. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression. Growth Hormone & IGF Research 2020;  doi: 10.1016/j.ghir.2020.101332
528
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004. Environmental Science and Pollution Research 2020; 27(6) doi: 10.1007/s11356-019-07066-x
529
Alexandra Zaborowski, Helen M. Heneghan, Barbara Fiore, Anthony Stafford, Tom Gallagher, Justin Geoghegan, Donal Maguire, Emir Hoti. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol. Transplantation 2020; 104(10) doi: 10.1097/TP.0000000000003114
530
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up. Hepatology 2020; 72(2) doi: 10.1002/hep.31040
531
Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jasmohan S. Bajaj. Reply. Liver Transplantation 2019; 25(10) doi: 10.1002/lt.25612
532
Mihaela Popescu, Kristina Radivojevic, Diana-Maria Trasca, Renata Maria Varut, Irina Enache, Andrei Osman. Natural Antidiabetic Agents: Insights into Ericaceae-Derived Phenolics and Their Role in Metabolic and Oxidative Modulation in Diabetes. Pharmaceuticals 2025; 18(5) doi: 10.3390/ph18050682
533
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. Nutrients 2021; 13(3) doi: 10.3390/nu13030959
534
Francesca De Vito, Velia Cassano, Elettra Mancuso, Elena Succurro, Marta Letizia Hribal, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti, Teresa Vanessa Fiorentino. Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD. Journal of Internal Medicine 2023; 294(3) doi: 10.1111/joim.13651
535
Jana Hudcova, Syed Talha Qasmi, Robin Ruthazer, Ahsan Waqas, Syed Basit Haider, Roman Schumann. Early Allograft Dysfunction Following Liver Transplant: Impact of Obesity, Diabetes, and Red Blood Cell Transfusion. Transplantation Proceedings 2021; 53(1) doi: 10.1016/j.transproceed.2020.02.168
536
Charlotte Wernicke, Anne Pohrt, Laura Pletsch-Borba, Konstantina Apostolopoulou, Silke Hornemann, Nina Meyer, Jürgen Machann, Christiana Gerbracht, Frank Tacke, Andreas FH Pfeiffer, Joachim Spranger, Knut Mai. Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial. The American Journal of Clinical Nutrition 2023; 117(4) doi: 10.1016/j.ajcnut.2023.01.010
537
Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH. Current Topics in Medicinal Chemistry 2023; 23(21) doi: 10.2174/1568026623666230714113808
538
Timothy M.E. Davis. Diabetes and metabolic dysfunction-associated fatty liver disease. Metabolism 2021; 123 doi: 10.1016/j.metabol.2021.154868
539
Yongjia Li, Xinming Su, Nidhi Rohatgi, Yan Zhang, Jonathan R. Brestoff, Kooresh I. Shoghi, Yalin Xu, Clay F. Semenkovich, Charles A. Harris, Lindsay L. Peterson, Katherine N. Weilbaecher, Steven L. Teitelbaum, Wei Zou. Hepatic lipids promote liver metastasis. JCI Insight 2020; 5(17) doi: 10.1172/jci.insight.136215
540
N. M. Delzenne, C. Knudsen, M. Beaumont, J. Rodriguez, A. M. Neyrinck, L. B. Bindels. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis. Proceedings of the Nutrition Society 2019; 78(3) doi: 10.1017/S0029665118002756
541
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020 doi: 10.1155/2020/8822859
542
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, Ashlie Santaliz-Casiano, Zeynep Madak-Erdogan. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style. Steroids 2024; 203 doi: 10.1016/j.steroids.2023.109330
543
Assim A. Alfadda, Adel N. Alqutub, Suphia M. Sherbeeni, Abdullah S. Aldosary, Saleh A. Alqahtani, Arthur Isnani, Rukhsana Gul, Mohammad S. Khaleel, Sara M. Alqasim, Abdulrahman M. Almaghamsi. Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD. Journal of Diabetes and its Complications 2025; 39(2) doi: 10.1016/j.jdiacomp.2024.108910
544
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696
545
Toshihiro Sakai, Hiroyuki Ohba, Shingo Nishiyama, Takeharu Kakiuchi, Osamu Inoue, Hideo Tsukada. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with 18F-BCPP-BF. EJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0420-6
546
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
547
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>. Drug Design, Development and Therapy 2020;  doi: 10.2147/DDDT.S258857
548
T. V. Fiorentino, S. Miceli, E. Succurro, A. Sciacqua, F. Andreozzi, G. Sesti. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiency. Journal of Internal Medicine 2021; 289(2) doi: 10.1111/joim.13155
549
Dayana Cabrera, Jorge Moncayo-Rizzo, Karen Cevallos, Geovanny Alvarado-Villa. Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador. Geriatrics 2023; 8(2) doi: 10.3390/geriatrics8020042
550
Arash Gholoobi, Mehrnoosh Gifani, Aida Gholoobi, Saeed Akhlaghi, Masoud Pezeshki Rad, Vafa Baradaran Rahimi. Relationship between the prevalence and severity of non‐alcoholic fatty liver disease and coronary artery disease: Findings from a cross‐sectional study of a referral center in northeast Iran. JGH Open 2022; 6(5) doi: 10.1002/jgh3.12746
551
Adrian T. Billeter, Sarah Wloka, Rouven Behnisch, Thomas Albrecht, Stephanie Roessler, Benjamin Goeppert, Sebastian Mueller, Felix Nickel, Beat Müller. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. Obesity Facts 2021; 14(5) doi: 10.1159/000517383
552
Ali Jafari, Helia Mardani, Bahare Parsi Nezhad, Azita Hekmatdoost. The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis. BMC Cardiovascular Disorders 2026; 26(1) doi: 10.1186/s12872-025-05433-w
553
Jun Tang, Nan Zheng, Yu-Xin Yan, Nan Zhang, Xiao-Mei Ren. 1990–2021 global, regional, and national analysis of the burden and trends of non-alcoholic fatty liver disease. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1609816
554
Long Le, Ravina Kullar, Hussein M. Saleh, Sammy Saab. Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2020; 65(12) doi: 10.1007/s10620-020-06382-4
555
Yunyeong Jang, Minjeong Ko, Ju Yeon Lee, Jin Young Kim, Eun-Woo Lee, Ho Jeong Kwon. Inhibition of lysosomal LAMTOR1 increases autophagy by suppressing the MTORC1 pathway to ameliorate lipid accumulations in MAFLD. Autophagy 2025; 21(12) doi: 10.1080/15548627.2025.2519054
556
Sonika Verma, Manish Verma, Sunny Khari. Association of Hematological Parameters (Mean Platelet Volume and Red Cell Distribution Width) with Nonalcoholic Fatty Liver Disease. APIK Journal of Internal Medicine 2023; 11(1) doi: 10.4103/ajim.ajim_11_22
557
Aunchalee Jaroenlapnopparat, Thanitsara Rittiphairoj, Natapat Chaisidhivej, Bradley Walker, Nipith Charoenngam. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(8) doi: 10.1016/j.dsx.2023.102827
558
Ionel Sandovici, Tiago Morais, Miguel Constância, Mariana P Monteiro. Epigenetic Changes Associated With Obesity-related Metabolic Comorbidities. Journal of the Endocrine Society 2025; 9(9) doi: 10.1210/jendso/bvaf129
559
Gieira S. Jones, Barry I. Graubard, Christian S. Alvarez, Katherine A. McGlynn. Prediction of nonalcoholic fatty liver disease using anthropometry and body fat measures by sex and race/ethnicity in the United States. Obesity 2022; 30(9) doi: 10.1002/oby.23514
560
. 2020;  doi: 10.70675/5f36f175z7833z4e7cza284z097d946aa124
561
Seth A. Waits, Kyle H. Sheetz, Amir A. Ghaferi. Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis—Worth the Risk. JAMA Network Open 2019; 2(2) doi: 10.1001/jamanetworkopen.2019.0053
562
Bertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, Jose I. Riezu-Boj, Fermín I. Milagro, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jorge Quiroga, Ana Martinez-Echeverria, Juan Isidro Uriz-Otano, María Pilar Huarte-Muniesa, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls. Nutrients 2019; 11(2) doi: 10.3390/nu11020322
563
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer. Hepatic lipid droplet homeostasis and fatty liver disease. Seminars in Cell & Developmental Biology 2020; 108 doi: 10.1016/j.semcdb.2020.04.011
564
Yaning Biao, Jian Chen, Chenxu Liu, Ruilong Wang, Xue Han, Li Li, Yixin Zhang. Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.877924
565
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4) doi: 10.14366/usg.21182
566
Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk Factor. Journal of Clinical and Experimental Hepatology 2025; 15(5) doi: 10.1016/j.jceh.2025.102559
567
Chunbao Mo, Tingyu Mai, Jiansheng Cai, Haoyu He, Huaxiang Lu, Xu Tang, Quanhui Chen, Xia Xu, Chuntao Nong, Shuzhen Liu, Dechan Tan, Qiumei Liu, Min Xu, You Li, Zhiyong Zhang, Jian Qin. Association between TFEB gene polymorphism, gene–environment interaction, and fatty liver disease: A case–control study in China. Science Progress 2021; 104(3) doi: 10.1177/00368504211043766
568
. 2022;  doi: 10.70675/1716f226z5188z4febz8ff5z973e59906619
569
Qian Xie, Hu Li, Xiaotong Hu, Jie Wan, Xia Gao, Liang Huang, Yan Long, Xia Xu, Chunmao Jiang. Dose–response association between metabolic syndrome component count and metabolic dysfunction-associated fatty liver disease, and independent graded association of visceral fat area: a cross-sectional study in a health-checkup population. Frontiers in Public Health 2026; 14 doi: 10.3389/fpubh.2026.1842607
570
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation. Canadian Liver Journal 2021; 4(4) doi: 10.3138/canlivj-2021-0011
571
Gavin Low, Ryan K. W. Chee, Yu Jun Wong, Puneeta Tandon, Florin Manolea, Stephanie Locas, Craig Ferguson, Wendy Tu, Mitchell P. Wilson. Abbreviated Multiparametric MR Solution (the “Liver Triple Screen”), the Future of Non-Invasive MR Quantification of Liver Fat, Iron, and Fibrosis. Diagnostics 2024; 14(21) doi: 10.3390/diagnostics14212373
572
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, review. Annals of Medicine and Surgery 2020; 50 doi: 10.1016/j.amsu.2020.01.001
573
Haider Ghazanfar, Sameer D Kandhi, Iqra Nawaz, Nismat Javed, Minu C Abraham, Mohamed Farag, Jaydeep Mahasamudram, Vishwa B Patel, Faryal Altaf, Harish Patel. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article. Cureus 2021;  doi: 10.7759/cureus.15141
574
Jiří Hlušička, Aleš Žák. Dyslipidaemia in Liver Diseases. Folia Biologica 2024; 70(5-6) doi: 10.14712/fb2024070050239
575
Ali Canbay, Nandita Kachru, Jennifer Scarlet Haas, Jan‐Peter Sowa, Dominic Meise, Ahmet Burak Ozbay. Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease . Alimentary Pharmacology & Therapeutics 2020; 52(7) doi: 10.1111/apt.16016
576
Debmalya Sanyal, Subhankar Chowdhury, Soumik Goswami, Arundhati Dasgupta, Amarta Shankar Chowdhury, Sunetra Mondal, Supratik Bhattacharyya, Soumyabrata Roy Chowdhury, Mahuya Sikdar. Prevalence of Hepatic Fibrosis and Performance of Non-invasive Liver Fibrosis Scores in an Eastern Indian Diabetic Population with NAFLD. Journal of the ASEAN Federation of Endocrine Societies 2025; 40(2) doi: 10.15605/jafes.040.02.16
577
Eun Hye Cho, Jee Ah Kim, Min-Seung Park, Min-Jung Kwon, Hyosoon Park, Hee-Yeon Woo, Tyng-Yuan Jang. Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease. PLOS ONE 2025; 20(2) doi: 10.1371/journal.pone.0318847
578
Egor V. Kalinin, Yaroslava M. Chalenko, Elena V. Sysolyatina, Konstantin Y. Midiber, Alexey M. Gusarov, Olga I. Kechko, Alexandra A. Kulikova, Ludmila M. Mikhaleva, Andrey Ya. Mukhachev, Yaroslav M. Stanishevskyi, Vladimir A. Mitkevich, Konstantin A. Sobyanin, Svetlana A. Ermolaeva. Bacterial hepatocyte growth factor receptor agonist stimulates hepatocyte proliferation and accelerates liver regeneration in a partial hepatectomy rat model. Drug Development Research 2021; 82(1) doi: 10.1002/ddr.21737
579
Jitka Starekova, Sebastian Weingärtner, David R. Rutkowski, Garrett C. Fullerton, Won C. Bae, Hung P. Do, Ananth J. Madhuranthakam, Vadim Malis, Sheng Qing Lin, Suraj D. Serai, Takeshi Yokoo, Scott B. Reeder, Jean H. Brittain, Diego Hernando. Cross‐Vendor Validation of Proton Density Fat Fraction and T1 Mapping Using a Combined Proton Density Fat Fraction—T1 Phantom. Journal of Magnetic Resonance Imaging 2026; 64(2) doi: 10.1002/jmri.70344
580
Renzo Pajuelo-Vasquez, Jerry K. Benites-Meza, Hilda V. Durango-Chavez, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo. Diagnostic performance of the GGT/HDL-C ratio for NAFLD in adults with obesity undergoing bariatric surgery. Diabetes Research and Clinical Practice 2024; 211 doi: 10.1016/j.diabres.2024.111649
581
Cong Xie, Yulian Yuan, Yunjing Wang, Cong Qi, Wei Wang, Chuan An, Aifeila Aikepaer, Yaofu Zhang, Ge Zhang, Xingzhong Feng, Huijuan Gao. Beyond Discrete Diagnoses: Conceptualizing Obesity-associated Metabolic Disorders as a Unified, Dynamic Continuum. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00673-5
582
Tudor Mocan, Dong Wook Kang, Billy J. Molloy, Hyeonho Jeon, Zeno A. Spârchez, Diren Beyoğlu, Jeffrey R. Idle. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87921-5
583
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
584
Mary McCallum, Pauline Dundas, Ashis Mukhopadhya. Multidisciplinary pathway to support lifestyle change: tangible benefits in physical and mental health for patients with nonalcoholic fatty liver disease (NAFLD). Clinical Liver Disease 2023; 21(2) doi: 10.1097/CLD.0000000000000017
585
Kevin Craig, Marc Abrams, Mansoor Amiji. Cholesterol-Conjugated siRNA Silencing Tnf for the Treatment of Liver Macrophage-Mediated Acute Inflammation in Nonalcoholic Fatty Liver Disease . Nucleic Acid Therapeutics 2023; 33(1) doi: 10.1089/nat.2022.0038
586
María Martín-Grau, Mercedes Pardo-Tendero, Pilar Casanova, Mar Dromant, Vannina G. Marrachelli, Jose Manuel Morales, Consuelo Borrás, Serena Pisoni, Sabrina Maestrini, Anna M. Di Blasio, Daniel Monleon. Altered Lipid Moieties and Carbonyls in a Wistar Rat Dietary Model of Subclinical Fatty Liver: Potential Sex-Specific Biomarkers of Early Fatty Liver Disease?. Antioxidants 2023; 12(10) doi: 10.3390/antiox12101808
587
Kevin J. Filipski, Kentaro Futatsugi, Robert Dullea, Michelle R. Garnsey, Daniel J. Smaltz. 2024 Medicinal Chemistry Reviews. Medicinal Chemistry Reviews 2024; 59 doi: 10.1021/mc-2024-vol59.ch05
588
Tannaz Jamialahmadi, Mehdi Azizmohammad Looha, Sara Jangjoo, Nima Emami, Mohammed Altigani Abdalla, Mohammadreza Ganjali, Sepideh Salehabadi, Sercan Karav, Thozhukat Sathyapalan, Ali H. Eid, Ali Jangjoo, Amirhossein Sahebkar. Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models. Journal of Diabetes & Metabolic Disorders 2025; 24(1) doi: 10.1007/s40200-025-01564-1
589
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2020.9630
590
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?. Journal of Clinical Medicine 2021; 10(5) doi: 10.3390/jcm10050924
591
Huimin Zou, Ying Ge, Qing Lei, Carolina Oi Lam Ung, Zhen Ruan, Yunfeng Lai, Dongning Yao, Hao Hu. Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review. Hepatology International 2022; 16(1) doi: 10.1007/s12072-021-10286-4
592
Ya-Ping Huang, Shi Zhang, Minying Zhang, Yi Wang, Wen-Hong Wang, Jing Li, Chunjun Li, Jing-Na Lin. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study. BMJ Open 2021; 11(12) doi: 10.1136/bmjopen-2021-056260
593
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. Journal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
594
M. A. Livzan, M. I. Syrovenko, T. S. Krolevets. Non-alcoholic fatty liver disease and the risk of malignant tumors. Meditsinskiy sovet = Medical Council 2023; (18) doi: 10.21518/ms2023-355
595
Luan Chen, Jie Zhang, Jing-yi Peng, Yuan Yuan, Yang Ding, Yi Wang, Xing-xing He. Global and Country-Level Analysis of Liver Cancer: Disease Burden and Recent Trends. Current Medical Science 2025; 45(3) doi: 10.1007/s11596-025-00064-w
596
Cindy X. Cai, Stella Carlos, Pejman Solaimani, Bansari J. Trivedi, Chuong Tran, Shobha Castelino-Prabhu. Dietary Interventions in Liver Disease. 2019;  doi: 10.1016/B978-0-12-814466-4.00029-X
597
Snigdha Jyoti Das, Barsha Pathak, Sangit Dutta, Sujoy Bose, Purabi Deka Bose. Role of serum endotoxin, FGF19, TLR2, TNF-α, IL-12 and IL-10 in NAFLD-associated T2DM pathogenesis: Insights into Th1 bias and protective mechanisms. Indian Journal of Gastroenterology 2024;  doi: 10.1007/s12664-024-01597-z
598
Laura Huiban, Anca Trifan, Carol Stanciu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023;  doi: 10.1007/978-3-031-33548-8_20
599
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients . Metabolic Syndrome and Related Disorders 2022; 20(2) doi: 10.1089/met.2020.0104
600
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn. Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”. Clinical and Molecular Hepatology 2023; 29(1) doi: 10.3350/cmh.2022.0375
601
Ruanchang Chen, Fangzheng Zhou, Jiayao Zhang, Huanjun Tong, Baochun Lu. Nine anthropometric indices predict hepatic steatosis and assess liver health in adolescents: a population-based study. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1558023
602
Navia Vinoy, Gary Huang, Daniel F. Wallace, V. Nathan Subramaniam. Peroxisome Dysfunction and Steatotic Liver Disease. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178303
603
Katie Shen, Achintya D Singh, Jamak Modaresi Esfeh, Jamile Wakim-Fleming. Therapies for non-alcoholic fatty liver disease: A 2022 update. World Journal of Hepatology 2022; 14(9): 1718-1729 doi: 10.4254/wjh.v14.i9.1718
604
Janus Ong, Khalid Alswat, Saeed Hamid, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region. Clinics in Liver Disease 2023; 27(2) doi: 10.1016/j.cld.2023.01.014
605
Vinod K. Rustgi, You Li, Tina John, Carolyn Catalano, Mohamed I. Elsaid. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims Analysis. Hepatology Communications 2020; 4(10) doi: 10.1002/hep4.1573
606
Michael G. Ross, Mina Desai. Genetic Disorders and the Fetus. 2021;  doi: 10.1002/9781119676980.ch5
607
Kuang-Chen Yen, Po-Chin Liang, Yueh-Hsun Lu, Cheng-Fu Ni, Chia-Hsun Lu, Li-Pin Chen, Chih-Horng Wu. Multi-vendor, multi-field strength validation of MRI-Proton density fat fraction for fat quantification: A standardized phantom study. Journal of the Formosan Medical Association 2026;  doi: 10.1016/j.jfma.2026.04.011
608
Camelia Munteanu, Betty Schwartz. The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease. Antioxidants 2023; 12(4) doi: 10.3390/antiox12040903
609
Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00082
610
Dongxu Wang, Nan Nan, Hao Bing, Bing He. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1241734
611
Hilal Ahmad Mir, Roshia Ali, Umar Mushtaq, Firdous A. Khanday. Structure-functional implications of longevity protein p66Shc in health and disease. Ageing Research Reviews 2020; 63 doi: 10.1016/j.arr.2020.101139
612
Natalia Zhelezniakova, Iryna Tverezovska. Diagnostic and prognostic value of selenium and Selenoprotein P in patients with comorbid course of nonalcoholic fatty liver disease and arterial hypertension. Medicinski casopis 2022; 56(2) doi: 10.5937/mckg56-36421
613
Gözde Arslanbulut, Seda Çiftçi. Exploring the link between fructose intake and Non-Alcoholic Fatty Liver Disease (NAFLD). Cahiers de Nutrition et de Diététique 2023; 58(6) doi: 10.1016/j.cnd.2023.10.004
614
Ewelina Młynarska, Witold Czarnik, Natasza Dzieża, Weronika Jędraszak, Gabriela Majchrowicz, Filip Prusinowski, Magdalena Stabrawa, Jacek Rysz, Beata Franczyk. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26031094
615
Hossein Saneian, Leila Khalilian, Motahar Heidari-Beni, Majid Khademian, Fatemeh Famouri, Peyman Nasri, Akbar Hassanzadeh, Roya Kelishadi. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial. Journal of Pediatric Endocrinology and Metabolism 2021; 34(7) doi: 10.1515/jpem-2020-0642
616
T. S. Krolevets, M. A. Livzan, M. I. Syrovenko. The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease. Meditsinskiy sovet = Medical Council 2024; (8) doi: 10.21518/ms2024-009
617
Karn Wijarnpreecha, Melissa Scribani, Pascale Raymond, Denise M Harnois, Andrew P Keaveny, Aijaz Ahmed, Donghee Kim. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. Journal of Gastroenterology and Hepatology 2020; 35(10) doi: 10.1111/jgh.15045
618
Shahinul Alam, Md. Saiful Islam Alin, Farhana Begum, Shah Mohammad Fahim, Zareen Tasnim, Md. Mahabubul Alam. Estimating the cost of illness of non‐alcoholic fatty liver disease in Bangladesh. JGH Open 2023; 7(9) doi: 10.1002/jgh3.12960
619
Wassiem Takhman, Mohammad A. Nour, Anas Merai, Lubna Saudi, Mosab Maree, Ahmed Awad ghanem, Jihad Hamaida, Basma Damiri. Characteristics of non-alcoholic fatty liver disease in Palestinian diabetics: A cross-sectional study. Palestinian Medical and Pharmaceutical Journal 2023; 8(3) doi: 10.59049/2790-0231.1250
620
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care Physicians. Diabetes Technology & Therapeutics 2019; 21(11) doi: 10.1089/dia.2019.0158
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.